Mixed hyperlipidaemia

E4_HYPERLIPMIX

obsolete_familial combined hyperlipidemia: ['A type of familial lipid metabolism disorder characterized by a variable pattern of elevated plasma CHOLESTEROL and/or TRIGLYCERIDES. Multiple genes on different chromosomes may be involved, such as the major late transcription factor (UPSTREAM STIMULATORY FACTORS) on CHROMOSOME 1.']

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E78.2 Hospital discharge: ICD-9 — 2722 Cause of death: ICD-10 — E78.2 Cause of death: ICD-9 — 2722 2 out of 7 registries used, show all original rules.	1836
4. Check minimum number of events None	1836
5. Include endpoints None	1836
6. Filter based on genotype QC (FinnGen only)	1621

Control definitions (FinnGen only)

Control exclude: E4_METABOLIA

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: E78

NAME	E4_HYPERLIPMIX
CONTROL_EXCLUDE	E4_METABOLIA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E782
HD_ICD_9	2722
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E782
COD_ICD_9	2722
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Mixed hyperlipidaemia based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	9795	3468	6263
Only index persons	8546	3081	5465
Unadjusted period prevalence (%)
Whole population	0.15	0.10	0.17
Only index persons	0.17	0.11	0.21
Median age at first event (years)
Whole population	57.21	62.08	54.43
Only index persons	56.64	61.35	53.98

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1621	595	1026
Unadjusted period prevalence (%)	0.38	0.21	0.47
Median age at first event (years)	56.69	59.08	55.30

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1673: Matched controls
16730

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

C10AB05

ATC

fenofibrate; oral

28.0

319.9

222

E66.00

ICD-10 Finland

Metabolic syndrome

12.3

307.7

356

360

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

6.9

307.7

923

2532

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

16.2

307.7

360

278

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

4614.0

307.7

1228

E78.2

ICD-10 Finland

Mixed hyperlipidaemia

1746.8

305.8

288

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

45.6

295.6

176

103

Kela drug reimbursment

Diabetes, insulin-treated

6.0

293.6

938

2952

A10BA02

ATC

metformin; oral

5.5

264.5

943

3194

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

10.2

260.2

325

388

215

Kela drug reimbursment

Diabetes, non-insulin-treated

5.4

259.2

830

2564

C10AX09

ATC

ezetimibe; oral

6.0

257.1

623

1512

C10AB02

ATC

bezafibrate; oral

31.2

247.7

164

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

5.8

240.3

591

1444

C10AA05

ATC

atorvastatin; oral

5.0

219.0

1144

5027

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

5.1

216.7

633

1773

C10AA01

ATC

simvastatin; oral

4.8

210.9

1102

4799

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

7.6

200.3

318

500

A10AE04

ATC

insulin glargine; parenteral

6.2

198.6

400

802

T90

ICPC

Diabetes non-insulin dependent

4.5

196.2

768

2669

A10AB05

ATC

insulin aspart; parenteral

6.9

188.2

328

568

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

22.0

178.2

134

C01DA14

ATC

isosorbide mononitrate; oral

4.8

177.1

511

1391

I25.1

ICD-10 Finland

Atherosclerotic heart disease

4.3

175.5

683

2331

E78.21

ICD-10 Finland

Remnant hyperlipidemia

+∞

175.1

165

A10AC01

ATC

insulin (human); parenteral

6.5

166.7

307

559

Angiography of the heart and coronary arteries

7.0

164.6

280

470

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

5.2

161.0

398

948

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

6.7

148.8

260

447

I25.2

ICD-10 Finland

Old myocardial infarction

6.1

146.5

284

541

2722A

ICD-9 Finland

Disorders of lipoid metabolism, Mixed hyperlipidaemia

+∞

143.9

136

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

6.8

142.1

243

408

A10AE05

ATC

insulin detemir; parenteral

7.0

138.4

228

368

205

Kela drug reimbursment

Chronic hypertension

3.5

137.2

747

3103

I10

ICD-10 Finland

Essential (primary) hypertension

4.3

132.2

1352

8258

C10AA07

ATC

rosuvastatin; oral

3.4

129.7

824

3734

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

3.5

127.8

669

2688

B01AC04

ATC

clopidogrel; oral

3.9

126.4

470

1508

B04AB02, ,

ATC

13.2

124.3

121

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

3.5

122.7

618

2414

C10AB04

ATC

gemfibrozil; oral

22.3

122.6

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

8.0

120.4

172

236

A10BJ06

ATC

semaglutide; parenteral

6.3

118.1

216

386

SPAT1262

SPAT

Handing over of treatment supplies

3.7

117.8

500

1745

A10BH01

ATC

sitagliptin; oral

4.5

116.1

328

856

E11

ICD-10 Finland

Type 2 diabetes mellitus

3.7

115.5

468

1582

C10AA03

ATC

pravastatin; oral

5.3

115.4

256

547

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

5.2

112.8

260

574

E66.01

ICD-10 Finland

Obesity due to excess calories

5.1

112.4

264

592

A10BB12

ATC

glimepiride; oral

5.1

112.4

264

592

C10AA04

ATC

fluvastatin; oral

4.8

109.0

280

676

C03CA01

ATC

furosemide; systemic

3.1

106.0

745

3484

E78.11

ICD-10 Finland

Other hypertriglyceridemia

56.5

106.0

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

3.4

103.8

504

1897

A10BK03

ATC

empagliflozin; oral

4.1

102.6

335

969

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

8.0

101.3

143

193

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

4.3

100.8

296

791

B04AC02, ,

ATC

29.8

99.2

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

6.4

98.9

174

298

AN1

Coronary angiography

4.0

97.5

323

942

C07AB02

ATC

metoprolol; systemic

3.1

90.4

506

2051

B04AC04, ,

ATC

22.1

86.2

C07AB07

ATC

bisoprolol; oral

2.7

84.8

1044

6315

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

12.6

84.5

A10AD05

ATC

insulin aspart; parenteral

11.3

83.3

E66.8

ICD-10 Finland

Other obesity

5.9

83.2

159

294

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

6.8

82.7

134

210

160

Kela drug reimbursment

exenatide

9.4

82.4

101

114

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

4.0

82.3

268

767

M04AA01

ATC

allopurinol; systemic

3.3

81.8

389

1424

C10AA02

ATC

lovastatin; oral

6.3

81.4

144

247

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.8

81.0

623

2969

A10BK01

ATC

dapagliflozin; oral

4.1

79.4

241

655

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

8.3

78.6

106

135

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

6.0

75.4

139

248

A10BJ02

ATC

liraglutide; parenteral

7.2

75.3

115

169

C03DA01

ATC

spironolactone; oral

3.3

74.1

329

1150

C08CA01

ATC

amlodipine; oral

2.5

74.0

834

4730

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

7.4

73.5

110

158

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

6.5

71.9

121

197

A10BB01

ATC

glibenclamide; oral

5.3

71.6

151

305

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

4.3

69.8

196

501

R07.4

ICD-10 Finland

Chest pain, unspecified

2.6

69.6

603

3005

E87.5

ICD-10 Finland

Hyperkalaemia

21.4

69.2

C09AA02

ATC

enalapril; systemic

2.7

68.8

474

2108

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

9.6

68.8

A10BX01

ATC

guar gum; oral

5.6

67.9

136

262

A10BG03

ATC

pioglitazone; oral

6.6

66.5

111

179

I20.09

ICD-10 Finland

Unstable angina

4.6

66.2

167

392

XCK10

NOMESCO Finland

Photography of fundus of eye

3.5

65.5

254

812

E86

ICD-10 Finland

Volume depletion

29.4

64.3

I50.9

ICD-10 Finland

Heart failure, unspecified

2.9

63.6

359

1432

H3600, E113,

ICD-10 Finland

11.2

62.9

I20.00

ICD-10 Finland

Unstable angina

6.4

62.8

107

176

B01AC06

ATC

acetylsalicylic acid; oral

5.8

62.3

119

219

4019X

ICD-9 Finland

Essential hypertension, Unspecified

5.9

61.0

113

202

211

Kela drug reimbursment

Severe hereditary disorders of lipid metabolism (familial hypercholesterolaemia and type III dyslipoproteinemia)

26.9

61.0

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

5.2

59.9

128

261

A10AE06

ATC

insulin degludec; parenteral

5.9

59.3

110

197

Coronary artery bypass surgery

7.2

58.8

129

H36.01

ICD-10 Finland

Diabetic maculopathy

10.7

58.2

A10BX07

ATC

[U] liraglutide

10.1

57.5

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

4.2

57.3

165

428

G47.3

ICD-10 Finland

Sleep apnoea

2.4

57.2

529

2674

177

Kela drug reimbursment

Insulin glargine 300 U / ml

8.9

57.1

Single vessel balloon catheter extension

6.9

56.0

133

H3601, E113,

ICD-10 Finland

8.7

55.2

A10AB04

ATC

insulin lispro; parenteral

6.3

55.1

158

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

4.6

54.7

138

323

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

6.0

54.3

174

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

4.2

54.2

152

386

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

7.6

54.1

107

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

4.4

53.9

142

344

N18.8

ICD-10 Finland

Other chronic renal failure

6.6

53.2

137

C02AC05

ATC

moxonidine; oral

4.4

52.8

138

332

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

4.5

52.3

136

326

A10AB01

ATC

insulin (human); parenteral

5.9

51.6

172

I20.90

ICD-10 Finland

Angina pectoris, unspecified

5.3

51.6

108

216

C09AA05

ATC

ramipril; oral

2.3

50.5

540

2881

C07AG02

ATC

carvedilol; oral

3.8

50.5

168

482

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

6.9

49.9

117

A10BX04

ATC

[U] exenatide

11.1

49.7

XF402

NOMESCO Finland

ECG with work load test

3.0

49.6

241

876

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

11.1

48.8

4130B

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]

7.2

48.5

105

B01AC07

ATC

dipyridamole; systemic

4.3

48.0

132

330

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.5

47.2

174

534

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

4.2

47.1

133

339

E87.6

ICD-10 Finland

Hypokalaemia

8.6

46.5

C08CA13

ATC

lercanidipine; oral

2.6

46.4

326

1435

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

10.9

46.3

B04AB01, ,

ATC

9.8

46.1

A10AA02, ,

ATC

5.5

45.9

173

I25

ICD-10 Finland

Chronic ischaemic heart disease

4.1

45.6

133

347

T89

ICPC

Diabetes insulin dependent

4.7

45.6

110

248

E66.0

ICD-10 Finland

Obesity due to excess calories

10.5

45.0

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

4.4

44.9

116

276

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.4

44.8

392

1907

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

6.3

44.6

128

I50.0

ICD-10 Finland

Congestive heart failure

3.2

44.6

193

654

162

Kela drug reimbursment

liraglutide

9.0

44.2

N02AX02

ATC

tramadol; systemic, rectal

2.0

43.7

817

5336

M10.9

ICD-10 Finland

Gout, unspecified

3.1

43.2

196

683

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

43.1

896

6065

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.4

43.0

369

1776

A11CC03

ATC

alfacalcidol; systemic

6.5

42.9

113

I20.99

ICD-10 Finland

Angina pectoris, unspecified

3.4

42.7

165

521

H36.00

ICD-10 Finland

Diabetic background retinopathy

8.9

42.4

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

3.5

42.3

156

478

N03AX16

ATC

[U] pregabalin

2.2

42.2

436

2269

4100X

ICD-9 Finland

Acute myocardial infarction, Of anterolateral wall[INFARCTUS MYOCARDII ACUTUS DEFINITUS,MÄÄRITTELEMÄT]

6.5

42.1

112

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

14.4

41.7

I20.01

ICD-10 Finland

Unstable angina

5.1

41.6

185

C10BA02

ATC

simvastatin and ezetimibe; oral, topical

8.9

41.5

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

8.1

41.5

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

6.2

41.2

118

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

4.4

41.1

107

256

R06.0

ICD-10 Finland

Dyspnoea

2.1

40.6

518

2922

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

3.9

40.3

122

327

A10BD07

ATC

metformin and sitagliptin; systemic

3.9

40.0

124

338

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

6.6

38.6

A10BJ05

ATC

dulaglutide; parenteral

6.0

38.2

120

A10AD01

ATC

insulin (human); parenteral

6.8

38.0

A10BH05

ATC

linagliptin; oral

3.6

37.1

131

390

C03AA03

ATC

hydrochlorothiazide; oral

2.8

36.6

202

782

E78.49

ICD-10 Finland

Other hyperlipidaemia

12.7

35.8

C09BA02

ATC

enalapril and diuretics; systemic

2.8

35.8

192

732

4120B

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,AHTAUTUNUT]

7.5

35.3

AN4

Balloon angioplasty and drug eluding stent

4.6

35.1

192

TK800

NOMESCO Finland

Hemodialysis

5.6

34.1

119

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.0

34.1

538

3242

XF400

NOMESCO Finland

ECG with 12 standard connections

2.3

34.0

309

1510

4120X

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,MÄÄRITTELEMÄT]

7.5

34.0

E78.40

ICD-10 Finland

Familial combined hyperlipidaemia

333.5

33.0

C08CA02

ATC

felodipine; oral

2.6

32.6

208

865

RD210, ,

NOMESCO Finland

6.9

32.4

J01FF01

ATC

clindamycin; systemic

2.0

32.0

500

2991

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.8

31.9

168

633

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

31.8

576

3618

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

8.7

31.5

A02BC02

ATC

pantoprazole; systemic

1.9

31.4

1164

9121

4130X

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]

5.7

31.3

107

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.5

30.8

208

888

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

6.6

30.8

A10BG02

ATC

rosiglitazone; oral

6.0

30.7

NHQ40

NOMESCO Finland

Amputation of toe

6.5

30.4

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

3.9

30.1

243

SPAT1249

SPAT

Treatment-related counselling outside office

1.8

29.6

658

4386

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.0

29.3

443

2607

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.7

28.9

274

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.2

28.4

260

1269

A12AA04

ATC

calcium carbonate; oral

6.5

28.2

A10BJ01

ATC

exenatide; parenteral

8.1

28.2

H3603, E113,

ICD-10 Finland

8.5

27.9

PE1AT

NOMESCO Finland

Femoral artery PTA

7.4

27.6

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

2.9

27.6

139

511

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

3.1

27.5

123

423

4140B

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Coronary atherosclerosis[ATHEROSCLEROSIS ARTER CORON CORDIS,AHTAUTUNUT]

7.8

27.3

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

5.5

27.2

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.3

27.2

243

1172

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

4.4

27.1

162

C03BA11

ATC

indapamide; oral

4.3

27.0

167

Z3231

NOMESCO Finland

Registered nurse

1.9

26.9

463

2832

J01DB01

ATC

cefalexin; oral

2.0

25.8

1355

11439

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.9

25.7

391

2294

A10BB07

ATC

glipizide; oral

6.2

25.5

A28

ICPC

Limited function/disability NOS

2.0

25.5

331

1838

T82

ICPC

Obesity

3.8

25.5

215

R07.3

ICD-10 Finland

Other chest pain

2.3

25.5

203

932

ZXD05

NOMESCO Finland

Urgent procedure

1.8

25.5

482

3030

N19

ICD-10 Finland

Unspecified kidney failure

3.6

25.5

253

I50.1

ICD-10 Finland

Left ventricular failure

2.9

25.4

121

431

H3601, E103,

ICD-10 Finland

10.5

25.4

H3600, E103,

ICD-10 Finland

9.5

25.3

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.6

25.3

161

666

E66.9

ICD-10 Finland

Obesity, unspecified

3.9

25.2

198

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

25.2

674

4684

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

5.0

25.2

114

N05CF01

ATC

zopiclone; oral

1.8

24.9

549

3609

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

4.5

24.7

140

280

Kela drug reimbursment

Clopidogrel

5.8

24.7

N06AB04

ATC

citalopram; systemic

1.9

24.5

347

1984

A46

ICD-10 Finland

Erysipelas

2.0

24.5

295

1594

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.6

24.3

149

606

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

4.8

24.2

118

N06AA09

ATC

amitriptyline; systemic

2.4

24.1

180

803

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

5.7

24.0

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

4.6

23.9

127

3015

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

21.0

23.9

C02DE02, ,

ATC

5.5

23.9

I20.91

ICD-10 Finland

Angina pectoris, unspecified

5.9

23.7

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

6.0

23.6

N18.3

ICD-10 Finland

Chronic kidney disease, stage 3

4.5

23.5

133

N18.0

ICD-10 Finland

End-stage renal disease

6.7

23.4

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.9

23.4

113

405

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

6.0

23.1

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.1

23.1

321

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

5.6

23.0

201

Kela drug reimbursment

Chronic cardiac insufficiency

2.7

22.9

132

520

C07AB03

ATC

atenolol; systemic

2.7

22.9

127

491

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

5.2

22.7

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

4.0

22.6

163

A10AB06

ATC

insulin glulisine; parenteral

7.1

22.5

B01AA03

ATC

warfarin; systemic

1.9

22.4

365

2177

N05BA04

ATC

oxazepam; oral

1.8

22.4

424

2651

R5140

NOMESCO Finland

Monitoring the use of the aid

2.1

22.3

223

1122

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.0

22.3

256

1357

Z49.1

ICD-10 Finland

Extracorporeal dialysis

5.7

22.2

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

5.1

22.1

XF600

NOMESCO Finland

Bloodpressure measurement

2.7

22.1

121

464

Z3226

NOMESCO Finland

Physiotherapist

2.0

22.1

294

1641

L17

ICPC

Foot/toe symptom/complaint

1.7

22.1

491

3214

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

3.4

22.1

237

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.4

21.9

164

731

C07AB08

ATC

celiprolol; oral

3.7

21.9

190

L28

ICPC

Limited function/disability (L)

1.9

21.9

336

1966

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

21.8

721

5242

R53

ICD-10 Finland

Malaise and fatigue

1.8

21.8

391

2401

A10AA01, ,

ATC

4.6

21.8

116

C10AX13

ATC

evolocumab; parenteral

18.7

21.8

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

18.7

21.8

C09CA01

ATC

losartan; oral

1.8

21.7

469

3042

C08CA07

ATC

nisoldipine; oral

6.0

21.4

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

21.4

382

2342

D64.9

ICD-10 Finland

Anaemia, unspecified

2.1

21.4

215

1083

A10BD03

ATC

metformin and rosiglitazone; systemic

4.7

21.3

106

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

5.5

21.2

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

21.2

333

1962

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

8.1

20.9

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.2

20.8

197

968

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

5.8

20.7

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.2

20.7

181

861

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

20.7

576

3993

ZXE00

NOMESCO Finland

One hour or less

1.7

20.7

599

4196

V03AE01

ATC

polystyrene sulfonate; oral

5.7

20.4

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

20.4

464

3044

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.9

20.4

303

1751

S97

ICPC

Chronic ulcer skin

2.5

20.2

137

583

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

6.3

20.2

N06AX16

ATC

venlafaxine; oral

2.1

20.2

214

1098

C08DB01

ATC

diltiazem; oral

2.8

20.2

108

409

EBA00

NOMESCO Finland

Extraction of tooth

1.7

20.2

593

4162

358

Kela drug reimbursment

liraglutide

8.5

20.2

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.0

20.1

240

1287

SPAT1263

SPAT

Sampling

1.6

20.1

649

4665

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.8

20.0

100

366

294

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

21.1

20.0

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

19.9

473

3137

J01DA01

ATC

[U] cefalexin

1.6

19.8

972

7723

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.0

19.8

245

1329

E78.10

ICD-10 Finland

Familial hypertriglyceridemia

+∞

19.8

2720X

ICD-9 Finland

Disorders of lipoid metabolism, Pure hypercholesterolaemia[HYPERCHOLESTEROLAEMIA ALIA]

+∞

19.8

M10

ICD-10 Finland

Gout

2.7

19.8

106

402

C08CA05

ATC

nifedipine; systemic

2.6

19.8

121

491

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

19.7

589

4146

N06AB10

ATC

escitalopram; oral

1.9

19.7

286

1638

R42

ICD-10 Finland

Dizziness and giddiness

1.8

19.7

377

2352

AA1

Conventional CABG

4.7

19.7

101

I35.0

ICD-10 Finland

Aortic (valve) stenosis

2.6

19.7

122

498

H03AA01

ATC

levothyroxine sodium; systemic

1.8

19.6

330

1980

N06AX11

ATC

mirtazapine; oral

1.7

19.6

537

3698

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

3.9

19.6

153

Z49.0

ICD-10 Finland

Preparatory care for dialysis

6.1

19.5

OAB50, ,

SPAT

2.3

19.5

165

774

C02EA02, ,

ATC

2.8

19.4

355

M10.0

ICD-10 Finland

Idiopathic gout

3.0

19.1

297

N02BE01

ATC

paracetamol; systemic, rectal

2.0

19.0

1463

13029

N05CD07

ATC

temazepam; oral

2.0

19.0

214

1123

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

18.7

268

1526

Catheterization and pressure measurement of the left side of the heart

4.6

18.7

101

J01MA02

ATC

ciprofloxacin; systemic

1.6

18.7

647

4707

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

21.1

18.6

N05BA01

ATC

diazepam; systemic, rectal

2.0

18.6

218

1160

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.9

18.4

325

R02

ICPC

Shortness of breath/dyspnoea

2.0

18.2

229

1248

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

3.7

18.2

161

SPAT1336

SPAT

Request for examination

3.3

18.0

216

FN2AB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon

4.4

17.9

105

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

7.0

17.8

N06AX21

ATC

duloxetine; oral

2.1

17.8

184

934

5314

FHL

Bypass surgery for four or more vessels

6.1

17.8

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

18.3

17.8

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

17.8

207

1098

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

17.6

306

1850

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

4.8

17.6

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.9

17.5

306

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

5.9

17.5

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.2

17.4

163

796

C10AC02

ATC

colestipol; oral

42.5

17.3

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.5

17.3

116

492

A02BA02

ATC

ranitidine; systemic

1.8

17.1

318

1959

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.0

17.1

255

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.9

17.0

250

1433

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

3.3

16.9

199

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.4

16.8

120

523

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.5

16.7

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.3

16.7

127

570

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.0

16.6

191

1008

AN2

Balloon angioplasty, including several vessels

3.5

16.5

167

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

16.3

576

4178

G63.2

ICD-10 Finland

Diabetic polyneuropathy

14.4

16.3

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

3.3

16.2

189

N05AH04

ATC

quetiapine; oral

1.8

16.2

271

1616

I50

ICD-10 Finland

Heart failure

3.2

16.1

205

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

5.2

16.0

4111X

ICD-9 Finland

Other acute and subacute forms of ischaemic heart disease, Intermediate coronary syndrome[PITKITTYNYT ANGINA PECTORIS -KOHTAUS,MÄÄRITTELEMÄT]

6.2

16.0

SPAT1281

SPAT

Other administrative function

2.2

15.9

133

620

212

Kela drug reimbursment

Gout

3.6

15.9

147

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

5.4

15.9

H04AA01

ATC

glucagon; nasal, parenteral

4.6

15.9

315

Kela drug reimbursment

Clopidogrel

5.8

15.9

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

15.9

433

2950

UJF32

NOMESCO Finland

Coloscopy

1.6

15.9

436

2976

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.0

15.8

186

989

B04AX03, ,

ATC

60.6

15.8

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

15.8

221

1247

C09CA06

ATC

candesartan; oral

1.7

15.7

385

2553

40199

ICD-8 Finland

Essential benign hypertension

4.2

15.7

103

H02AB06

ATC

prednisolone; systemic

1.5

15.7

758

5883

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

13.9

15.5

CKC15

NOMESCO Finland

Panretinal photocoagulation

6.3

15.5

FNC30

NOMESCO Finland

Aorto-coronary venous bypass with three distal anastomoses

4.4

15.5

AA1AD

NOMESCO Finland

CT of head and brain

1.6

15.5

469

3276

J01MA12

ATC

levofloxacin; systemic

1.7

15.4

321

2037

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

6.5

15.4

N03AX12

ATC

[U] gabapentin; oral

1.8

15.4

257

1531

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

15.3

218

1237

A02BC05

ATC

esomeprazole; systemic

1.5

15.2

617

4602

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

3.5

15.1

157

A41.9

ICD-10 Finland

Sepsis, unspecified

2.8

15.1

268

A12BA01

ATC

potassium chloride; oral

2.7

15.0

314

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

6.3

15.0

I21.19

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

4.4

15.0

111

Conventional CABG

5.8

14.9

FNE20

NOMESCO Finland

Coronary bypass using free arterial graft of radial artery

6.6

14.9

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

14.9

665

5055

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.2

14.8

131

625

PD4AD

NOMESCO Finland

CT of lower extremity arteries

6.0

14.8

I79.2*E11.5

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

16.6

14.8

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

4.5

14.8

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

3.7

14.8

126

N06AA12

ATC

doxepin; systemic

2.5

14.7

383

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.9

14.7

219

1258

R51.80

ICD-10 Finland

Headache

1.9

14.7

215

1228

CK2S4, ,

SPAT

4.0

14.7

108

R05FB02

ATC

cough suppressants and expectorants; systemic

1.5

14.7

574

4237

K99

ICPC

Cardiovascular disease other

3.1

14.7

201

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

5.2

14.6

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

12.0

14.6

C01BD01

ATC

amiodarone; systemic

3.0

14.6

218

E78.1

ICD-10 Finland

Pure hyperglyceridaemia

11.0

14.5

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

3.0

14.5

224

J01AA02

ATC

doxycycline; systemic

1.6

14.5

1240

10788

H3603, E103,

ICD-10 Finland

12.7

14.4

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

2.7

14.4

310

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.1

14.3

142

709

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

14.2

580

4317

C09CA03

ATC

valsartan; oral

2.0

14.2

171

917

CKC12

NOMESCO Finland

Photocoagulation of retina

2.6

14.1

342

5315

FHL

Bypass surgery using a mammary artery

4.6

14.0

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.0

14.0

167

892

M79.6

ICD-10 Finland

Pain in limb

1.5

13.9

656

5025

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

13.9

174

945

R11

ICD-10 Finland

Nausea and vomiting

2.2

13.8

125

602

Z71.8

ICD-10 Finland

Other specified counselling

1.6

13.8

469

3348

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

13.7

1090

9264

BEF00, ,

SPAT

5.8

13.7

E78

ICD-10 Finland

Disorders of lipoprotein metabolism and other lipidaemias

3.0

13.7

199

AN3

Balloon angioplasty and metallic stent

3.2

13.6

173

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.3

13.6

158

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

12.2

13.6

M54.5

ICD-10 Finland

Low back pain

1.5

13.6

533

3926

A02BC03

ATC

lansoprazole; oral

1.6

13.5

446

3161

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

2.3

13.5

102

456

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.1

13.5

135

676

C10AD06

ATC

acipimox; oral

141.1

13.5

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

2.1

13.3

123

597

H36.09

ICD-10 Finland

Diabetic retinopathy (E10-E14+ with common fourth character .3)

21.3

13.3

R80

ICD-10 Finland

Isolated proteinuria

6.4

13.3

PG1XE

NOMESCO Finland

Other ultrasound examination of blood vessel not elsewhere classified

6.4

13.3

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.6

13.3

383

2630

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

5.4

13.3

R03AC02

ATC

salbutamol; inhalant

1.5

13.3

805

6468

A02BC01

ATC

omeprazole; systemic

1.6

13.2

411

2871

A10BX09

ATC

[U] dapagliflozin

5.8

13.2

R4110

NOMESCO Finland

Physiotherapy

1.6

13.2

408

2846

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

4.0

13.2

JN3AD

NOMESCO Finland

Abdominal CT examination

1.8

13.2

217

1284

M01AB01

ATC

indometacin; systemic, rectal

2.0

13.0

148

778

A06AD11

ATC

lactulose; oral

1.7

12.9

247

1526

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

2.4

12.9

358

B01AB05

ATC

enoxaparin; parenteral

1.5

12.8

481

3499

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

11.6

12.8

R55

ICD-10 Finland

Syncope and collapse

1.9

12.8

179

1008

E83.50

ICD-10 Finland

Hypercalcemia

10.6

12.8

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

4.0

12.7

I25.8

ICD-10 Finland

Other forms of chronic ischaemic heart disease

4.2

12.7

B01AF02

ATC

apixaban; oral

1.7

12.7

235

1439

P29

ICPC

Psychological sympt/compl other

2.3

12.6

437

Z02.7

ICD-10 Finland

Issue of medical certificate

2.1

12.6

121

597

C02CA01

ATC

prazosin; oral

3.8

12.6

102

E83.51

ICD-10 Finland

Hypocalcemia

32.3

12.6

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.2

12.5

106

497

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

12.5

217

1304

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.5

12.4

303

C02DE04, ,

ATC

3.3

12.4

147

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.3

12.4

137

P03

ICPC

Feeling depressed

2.1

12.4

117

574

C09DA01

ATC

losartan and diuretics; oral

1.8

12.3

187

1081

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

9.0

12.2

P01AB01

ATC

metronidazole; oral, rectal

1.5

12.2

556

4202

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

3.1

12.1

159

C07AA07

ATC

sotalol; systemic

2.6

12.1

271

104

Kela drug reimbursment

Thyroid insufficiency

2.3

12.1

439

E0000UV, ,

ATC

1.5

12.1

603

4640

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

9.3

12.0

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

2.2

12.0

460

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

5.1

12.0

J01CE02

ATC

phenoxymethylpenicillin; oral

1.5

11.9

1008

8550

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.7

11.9

232

XF602

NOMESCO Finland

Bloodpressure monitoring

4.9

11.9

CKC10

NOMESCO Finland

Local photocoagulation of retina

3.6

11.9

106

F32

ICD-10 Finland

Depressive episode

2.6

11.9

279

C10AC01

ATC

colestyramine; oral

3.1

11.9

161

H25.8

ICD-10 Finland

Other senile cataract

1.8

11.9

198

1175

E66

ICD-10 Finland

Obesity

2.4

11.8

335

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

10.6

11.8

M03BX02

ATC

tizanidine; oral

1.4

11.7

912

7607

B01AC24

ATC

ticagrelor; oral

2.5

11.7

293

N30.0

ICD-10 Finland

Acute cystitis

1.7

11.7

208

1257

N17.8

ICD-10 Finland

Other acute renal failure

4.4

11.7

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.7

11.7

246

Z94.0

ICD-10 Finland

Kidney transplant status

5.0

11.7

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

2.5

11.7

318

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

3.9

11.7

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.1

11.7

116

580

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

2.8

11.6

207

I44.2

ICD-10 Finland

Atrioventricular block, complete

2.7

11.6

224

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.1

11.6

115

574

N05BA12

ATC

alprazolam; oral

1.9

11.6

155

859

R06AE07

ATC

cetirizine; oral

1.5

11.6

589

4538

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

23.1

11.6

C09AA01

ATC

captopril; oral

3.3

11.5

128

C01AA05

ATC

digoxin; systemic

1.9

11.5

144

781

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

5.7

11.5

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

11.4

380

2685

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

4.2

11.3

127

Kela drug reimbursment

Transplant complication

4.2

11.3

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.7

11.3

233

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

11.3

574

4418

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

11.3

253

1628

K02.1

ICD-10 Finland

Caries of dentine

1.4

11.2

850

7033

207

Kela drug reimbursment

Chronic arrhythmias

1.6

11.2

276

1817

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.8

11.2

163

928

A10BD08

ATC

metformin and vildagliptin; systemic

4.8

11.2

137

Kela drug reimbursment

Uraemia requiring dialysis

5.6

11.2

H43.1

ICD-10 Finland

Vitreous haemorrhage

3.0

11.0

163

T92

ICPC

Gout

2.9

11.0

174

N03AX09

ATC

lamotrigine; oral

2.5

11.0

272

M48.0

ICD-10 Finland

Spinal stenosis

1.7

11.0

210

1296

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

10.9

160

913

A01

ICPC

Pain general/multiple sites

1.9

10.9

148

824

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

10.9

111

560

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

10.9

530

4042

FME20

NOMESCO Finland

Transvenous aortic valve replacement via femoral artery

4.3

10.8

SPAT1260

SPAT

Consultation of another employee

1.6

10.7

260

1704

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

10.7

416

3030

SPAT1097

SPAT

Recording of ECG

1.7

10.7

227

1439

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.7

10.7

211

1312

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

10.7

633

4999

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.0

10.7

120

627

SPAT1229

SPAT

Assessment of need for aid

2.0

10.7

124

656

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.9

10.7

130

699

S21

ICPC

Skin texture symptom/complaint

1.7

10.6

234

1497

J01CF05

ATC

flucloxacillin; systemic

2.0

10.6

114

586

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

5.3

10.6

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

10.6

660

5258

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

10.6

383

2750

A10BH02

ATC

vildagliptin; oral

3.3

10.6

120

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.6

10.5

236

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.5

10.5

SPAT1054

SPAT

Examination of peripheral nervous system

3.5

10.5

101

N02BF02

ATC

pregabalin; oral

2.1

10.4

102

507

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

10.4

486

3670

K05.31

ICD-10 Finland

Periodontitis pronounced

1.7

10.4

189

1150

PD3AT

NOMESCO Finland

Pelvic artery PTA

12.1

10.3

Z50.0

ICD-10 Finland

Cardiac rehabilitation

4.3

10.3

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

4.4

10.3

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.6

10.3

233

PE1YT

NOMESCO Finland

Femoral or popliteal artery PTA with stent

4.7

10.2

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.1

10.1

492

I42.0

ICD-10 Finland

Dilated cardiomyopathy

2.6

10.1

217

C07AB05

ATC

betaxolol; oral

2.9

10.1

166

J01FA06

ATC

roxithromycin; oral

1.4

10.1

577

4517

R4190

NOMESCO Finland

Nutritional therapy

2.5

10.1

259

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.9

10.1

136

756

196

Kela drug reimbursment

Paricalcitol and cinacalcet

8.5

10.0

C09DA07

ATC

telmisartan and diuretics; oral

2.4

10.0

309

D11

ICPC

Diarrhoea

1.8

10.0

157

914

K74

ICPC

Ischaemic heart dis with angina

4.5

10.0

QBJ30

NOMESCO Finland

Correction of abdominal apron

14.7

10.0

H02AB04

ATC

methylprednisolone; systemic

1.7

10.0

214

1359

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.5

9.9

261

E29.1

ICD-10 Finland

Testicular hypofunction

3.5

9.9

WX722

NOMESCO Finland

PEEP

2.2

9.9

415

EB1AA, ,

SPAT

2.1

9.9

442

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

16.8

9.9

ZX120

NOMESCO Finland

Intravenous

1.8

9.9

138

776

SPAT1255

SPAT

Intravenous administration of medicine

2.0

9.8

109

568

SFA10

NOMESCO Finland

One-surface restoration

1.4

9.8

793

6580

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.0

9.8

108

561

A10BX02

ATC

repaglinide; oral

3.8

9.8

3025

Kela drug reimbursment

Calcium carbonate

10.7

9.8

R60.0

ICD-10 Finland

Localized oedema

1.7

9.8

197

1232

Z2221

NOMESCO Finland

Medical doctor

1.5

9.7

364

2626

D29

ICPC

Digestive symptom/complaint other

3.0

9.7

137

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

3.7

9.7

N06AB06

ATC

sertraline; oral

1.8

9.7

147

847

ZXA00

NOMESCO Finland

Right side

1.5

9.7

394

2889

K92.1

ICD-10 Finland

Melaena

2.1

9.7

452

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

9.7

362

2610

C09AA03

ATC

lisinopril; oral

2.2

9.7

372

SFA20

NOMESCO Finland

Two-surface restoration

1.4

9.7

839

7037

321

Kela drug reimbursment

Paricalcitol and cinacalcet

5.3

9.6

Z50.1

ICD-10 Finland

Other physical therapy

2.1

9.6

413

J01DA09

ATC

[U] cefadroxil

1.5

9.6

374

2721

SPAT1254

SPAT

Administration of medicine

1.6

9.6

216

1390

M01AH02

ATC

rofecoxib; oral

1.7

9.5

195

1223

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

9.5

218

1407

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.8

9.5

137

777

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

9.5

268

1819

A10BD20

ATC

metformin and empagliflozin; oral

3.5

9.5

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.2

9.5

113

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

3.2

9.5

113

L04AA06

ATC

mycophenolic acid; systemic

3.3

9.5

103

J01MA01

ATC

ofloxacin; systemic

1.8

9.4

136

772

A11

ICPC

Chest pain NOS

1.8

9.4

133

750

E87.2

ICD-10 Finland

Acidosis

100.6

9.4

R52.9

ICD-10 Finland

Pain, unspecified

1.8

9.4

150

878

AP1

Catheterization of the left side of the heart

3.6

9.4

A99

ICPC

Disease/condition unspecnature/site

1.7

9.4

162

970

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

3.0

9.4

140

A08AB01

ATC

orlistat; oral

5.2

9.4

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.7

9.4

165

994

F60.9

ICD-10 Finland

Personality disorder, unspecified

4.4

9.3

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

3.8

9.3

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

9.3

291

2020

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

8.7

9.3

R31

ICD-10 Finland

Unspecified haematuria

1.7

9.3

184

1145

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.8

9.3

147

859

C09DA06

ATC

candesartan and diuretics; oral

1.9

9.3

122

673

EBA30

NOMESCO Finland

Extraction of root of tooth

2.0

9.3

107

565

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.0

9.3

104

544

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

9.3

256

1729

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

9.3

749

6195

XCH00

NOMESCO Finland

Eye pressure measurement

2.1

9.2

413

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

9.2

318

2253

J01CA04

ATC

amoxicillin; systemic

1.4

9.2

1227

11010

TLC00

NOMESCO Finland

Insertion of intrauterine device

2.8

9.2

169

CL2S4, ,

SPAT

2.8

9.2

158

PEN23

NOMESCO Finland

Plastic repair of femoral artery

5.0

9.1

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

3.8

9.1

ACC51

NOMESCO Finland

Release of median nerve

1.9

9.1

115

627

M79.1

ICD-10 Finland

Myalgia

1.6

9.0

197

1256

N02AA05

ATC

oxycodone; systemic

1.5

9.0

302

2126

F61.0

ICD-10 Finland

Mixed personality disorders

3.7

9.0

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

2.2

9.0

331

A04

ICPC

Weakness/tiredness general

1.6

8.9

212

1380

N05AX12

ATC

aripiprazole; systemic

2.5

8.9

213

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

8.9

796

6673

C09CA07

ATC

telmisartan; oral

1.9

8.9

121

674

41300

ICD-8 Finland

Angina pectoris, Cum hypertonia

24.1

8.9

PFP26

NOMESCO Finland

Percutaneous plastic repair of popliteal artery

24.1

8.9

A97

ICPC

No disease

1.5

8.9

289

2021

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

8.9

183

1150

K81.9

ICD-10 Finland

Cholecystitis, unspecified

4.0

8.9

5313

FHL

Bypass surgery for three vessels

8.0

8.9

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.5

8.8

214

A10AA03, ,

ATC

4.9

8.8

PEH57

NOMESCO Finland

Bypass from femoral artery to popliteal artery below knee

4.9

8.8

B03XA02

ATC

darbepoetin alfa; parenteral

2.9

8.8

145

XCK00

NOMESCO Finland

Perimetry

2.0

8.8

476

R06.2

ICD-10 Finland

Wheezing

2.2

8.8

321

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

8.7

8.8

S18

ICPC

Laceration/cut

1.4

8.8

741

6152

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

8.8

296

2086

R03BB04

ATC

tiotropium bromide; inhalant

1.7

8.8

168

1035

M01AE02

ATC

naproxen; oral, rectal

1.4

8.8

801

6733

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

9.5

8.8

R52.2

ICD-10 Finland

Other chronic pain

2.4

8.7

252

4140X

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Coronary atherosclerosis[ATHEROSCLEROSIS ARTER CORON CORDIS,MÄÄRITTELEMÄT]

7.2

8.7

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

8.7

252

1718

FL1AC

NOMESCO Finland

Left cardioangiography

3.2

8.7

109

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.9

8.7

105

564

N05CF02

ATC

zolpidem; oral

1.6

8.7

237

1596

PH2CD

NOMESCO Finland

Very extensive CT of inferior vena cava, pelvic veins and veins of lower extremity

7.7

8.6

U14

ICPC

Kidney symptom/complaint

3.3

8.6

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

2.6

8.6

187

L04AD02

ATC

tacrolimus; systemic

4.8

8.6

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.2

8.6

318

4110X

ICD-9 Finland

Other acute and subacute forms of ischaemic heart disease, Postmyocardial infarction syndrome[EPÄSTABIILI ANGINA PECTORIS,MÄÄRITTELEMÄT]

8.3

8.6

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

8.6

469

3624

H05BX01

ATC

cinacalcet; oral

6.4

8.5

B04AC01, ,

ATC

20.1

8.5

-50

ICPC

Medication/prescr/renewal

2.3

8.5

294

C08CA10

ATC

nilvadipine; oral

3.1

8.5

116

N17

ICPC

Vertigo/dizziness

1.6

8.4

181

1149

E78.3

ICD-10 Finland

Hyperchylomicronaemia

90.5

8.4

M02AA07

ATC

piroxicam; topical

1.4

8.4

532

4211

E10

ICD-10 Finland

Type 1 diabetes mellitus

3.5

8.4

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

8.4

323

2338

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

8.4

146

877

N06AX26

ATC

vortioxetine; oral

2.0

8.4

464

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

4.9

8.4

PE1BT

NOMESCO Finland

Femoral artery extensive PTA

4.9

8.4

T93

ICPC

Lipid disorder

1.8

8.4

118

666

SPAT1240

SPAT

Therapeutic discussion

1.8

8.4

118

666

E89.2

ICD-10 Finland

Postprocedural hypoparathyroidism

+∞

8.3

I79.2

ICD-10 Finland

Peripheral angiopathy in diseases classified elsewhere

+∞

8.3

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

8.3

129

749

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

10.8

8.3

TK810

NOMESCO Finland

Hemofiltration

9.5

8.3

WX872

NOMESCO Finland

Intensive care

2.1

8.3

404

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.9

8.2

134

WX892

NOMESCO Finland

Monitored bed care

1.8

8.2

113

632

K76.9

ICD-10 Finland

Liver disease, unspecified

3.5

8.2

J01EA01

ATC

trimethoprim; systemic

1.5

8.2

316

2286

R06.5

ICD-10 Finland

Mouth breathing

1.7

8.2

143

859

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.2

8.2

311

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

8.2

370

2759

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.7

8.2

163

Z3229

NOMESCO Finland

Other healthcare associate professional

1.8

8.2

128

746

CA1TM

NOMESCO Finland

Calculation of intraocular lens power

2.9

8.1

135

N06AB03

ATC

fluoxetine; oral

1.7

8.1

166

1041

K78

ICPC

Atrial fibrillation/flutter

1.8

8.1

128

748

PC5DE

NOMESCO Finland

Ultrasound of kidney circulation with Doppler technic

8.2

8.1

R03BA05

ATC

fluticasone; inhalant

1.5

8.1

242

1663

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.5

8.0

200

XA420

NOMESCO Finland

Extensive sleep examination

3.9

8.0

5253

FHL

Cardiac lung machine

3.9

8.0

K08.3

ICD-10 Finland

Retained dental root

1.8

8.0

129

759

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.7

8.0

148

D01

ICPC

Abdominal pain/cramps general

1.7

7.9

152

937

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

3.0

7.9

110

N06AX05

ATC

trazodone; oral

2.8

7.9

143

ZXA10

NOMESCO Finland

Bilateral

1.5

7.9

260

1822

JDF01

NOMESCO Finland

Laparoscopic gastroplasty

13.1

7.9

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

7.8

7.9

N02AC04

ATC

dextropropoxyphene; oral

2.3

7.9

271

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

7.8

337

2488

A29

ICPC

General symptom/complaint other

1.6

7.8

198

1308

WX110, ,

SPAT

2.1

7.8

364

L03

ICPC

Low back symptom/complaint

1.4

7.8

386

2922

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.5

7.8

203

Z72.0

ICD-10 Finland

Tobacco use

2.7

7.7

156

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.7

7.7

156

FN2CC

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of left main trunk

4.2

7.7

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

7.7

356

2661

SGA01

NOMESCO Finland

Emergency treatment

1.5

7.7

219

1485

WX199

NOMESCO Finland

Other local analgesia

2.2

7.7

273

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.6

7.7

162

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.7

7.7

152

944

S76

ICPC

Skin infection other

1.9

7.7

464

R4180

NOMESCO Finland

Podiatric therapy

3.5

7.7

C08CA03

ATC

isradipine; systemic

3.5

7.7

WX002

NOMESCO Finland

Sedation and analgesia

1.5

7.7

266

1883

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

7.7

415

3191

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.4

7.6

211

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

7.6

247

1724

SPAT1251

SPAT

Organisation of medication

2.3

7.6

230

XF640, ,

NOMESCO Finland

2.6

7.6

175

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.0

7.6

389

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.7

7.6

PEP25

NOMESCO Finland

Percutaneous plastic repair of superficial femoral artery

11.9

7.6

S10

ICPC

Boil/carbuncle

1.9

7.6

481

SPAT1211

SPAT

Application of soft bandage

1.7

7.5

125

741

M01AX17

ATC

nimesulide; oral

1.4

7.5

355

2666

J20

ICD-10 Finland

Acute bronchitis

1.7

7.5

138

842

SPAT1312

SPAT

General health counselling

1.4

7.5

428

3320

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.1

7.5

330

SPAT1252

SPAT

Overall medication plan or its review

1.8

7.5

104

585

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

2.2

7.5

297

K85

ICD-10 Finland

Acute pancreatitis

2.9

7.5

114

XCD20

NOMESCO Finland

Photoangiography of eye

3.1

7.4

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.7

7.4

142

875

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

7.4

197

1316

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

2.9

7.4

120

N30.9

ICD-10 Finland

Cystitis, unspecified

2.0

7.4

421

B03BA03

ATC

hydroxocobalamin; parenteral

1.9

7.4

485

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

7.4

392

3002

A02BA03

ATC

famotidine; systemic

2.2

7.4

285

K29

ICPC

Cardiovascular sympt/complt other

2.1

7.4

352

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.2

7.4

259

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

2.5

7.4

172

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

7.3

544

B82

ICPC

Anaemia other/unspecified

2.3

7.3

234

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

7.3

266

1900

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

7.3

218

1495

N0830, E112,

ICD-10 Finland

+∞

7.3

2724X

ICD-9 Finland

Disorders of lipoid metabolism, Other and unspecified hyperlipidaemia[HYPERLIPOIDAEMIA ALIA]

+∞

7.3

V03AE02

ATC

sevelamer; oral

6.9

7.3

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

6.9

7.3

2500X

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,NUD]

9.4

7.3

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

7.3

282

2040

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.9

7.3

488

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.4

7.3

210

C09AA04

ATC

perindopril; oral

2.0

7.2

403

B81

ICPC

Anaemia vit B12/folate deficiency

2.2

7.2

294

H3602, E113,

ICD-10 Finland

15.8

7.2

N06AX03

ATC

mianserin; oral

2.0

7.2

369

4740A

ICD-9 Finland

Chronic disease of tonsils and adenoids, Chronic tonsillitis

2.8

7.2

122

N07BB01

ATC

disulfiram; oral

2.1

7.2

342

S17

ICPC

Abrasion/scratch/blister

2.7

7.2

139

I21.10

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

4.0

7.2

UKC02

NOMESCO Finland

Cystoscopy

1.5

7.2

266

1908

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

7.2

476

M14.6*A52.1

ICD-10 Finland

Charcot's or tabetic arthropathy

20.1

7.1

R05DB05

ATC

pentoxyverine; oral, rectal

2.3

7.1

237

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

7.1

236

1654

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

3.3

7.1

I70.0

ICD-10 Finland

Atherosclerosis of aorta

6.6

7.1

TKC20

NOMESCO Finland

Catheterisation of bladder

1.8

7.1

105

602

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

3.0

7.1

101

FNC40

NOMESCO Finland

Aorto-coronary venous bypass with four distal anastomoses

4.1

7.1

M14.6*E11.6

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic neuropathic

12.1

7.1

WZC30

NOMESCO Finland

Teaching

1.5

7.1

251

1784

S06.0

ICD-10 Finland

Concussion

1.6

7.0

149

943

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

7.0

595

4896

C10AA06

ATC

cerivastatin; oral

10.1

7.0

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.9

7.0

486

I21.00

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

3.1

7.0

N05AX08

ATC

risperidone; systemic

1.7

7.0

128

779

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.4

7.0

207

ZXD20

NOMESCO Finland

Day surgery

1.6

7.0

167

1089

WX290

NOMESCO Finland

Other blockage of nerve

1.3

7.0

623

5165

FN2CA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), treating more than one main trunk during a single procedure

3.3

7.0

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

6.9

112

659

Z49.2

ICD-10 Finland

Other dialysis

5.5

6.9

NGQ20

NOMESCO Finland

Amputation of lower leg

5.9

6.9

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.8

6.9

104

600

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.8

6.9

104

600

R4120

NOMESCO Finland

Occupational therapy

1.9

6.9

468

C09BA03

ATC

lisinopril and diuretics; oral

2.5

6.9

160

E000003, ,

ATC

2.2

6.9

254

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

6.9

149

949

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

6.8

133

824

SPAT1325

SPAT

Vaccination

1.4

6.8

474

3785

SPAT1310

SPAT

Counselling related to known health issue

1.4

6.8

437

3448

ANC

Coronary artery pressure measurement (FFR, fractional flow reserve)

6.1

6.8

B05DB

ATC

Hypertonic solutions

6.1

6.8

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

6.8

415

3249

B04AD02, ,

ATC

40.2

6.8

NFQ20

NOMESCO Finland

Amputation of femur

4.3

6.8

27901

ICD-8 Finland

Other and unspecified metabolic diseases, Hyperlipaemia, hyperglyceridaemia non familiaris NUD

16.8

6.7

S09

ICPC

Infected finger/toe

2.3

6.7

230

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

0.6

6.7

113

1822

D07AC01

ATC

betamethasone; topical

1.3

6.7

529

4301

D19

ICPC

Teeth/gum symptom/complaint

1.4

6.7

409

3198

PEF25

NOMESCO Finland

Thrombendarterectomy of superficial femoral artery

7.2

6.7

I20.9

ICD-10 Finland

Angina pectoris, unspecified

3.3

6.7

S29

ICPC

Skin symptom/complaint other

1.4

6.7

286

2105

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.9

6.7

487

K29.7

ICD-10 Finland

Gastritis, unspecified

2.2

6.7

264

D02AE01

ATC

carbamide; topical

1.8

6.7

495

N39.1

ICD-10 Finland

Persistent proteinuria, unspecified

6.5

6.6

FN2CB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of coronary chronic total occlusion

6.5

6.6

FN1XT

NOMESCO Finland

Other coronary artery procedure through catheter

6.5

6.6

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.1

6.6

271

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

3.1

6.6

I95.1

ICD-10 Finland

Orthostatic hypotension

2.1

6.6

298

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.0

6.6

353

SPAT1283

SPAT

Restricted health certificate

1.6

6.6

150

966

L86

ICPC

Back syndrome with radiating pain

1.8

6.6

504

A41.8

ICD-10 Finland

Other specified sepsis

2.6

6.6

134

SFA30

NOMESCO Finland

Three-surface restoration

1.3

6.6

622

5189

I21.4

ICD-10 Finland

Acute subendocardial myocardial infarction

3.3

6.6

D07AB08

ATC

desonide; topical

1.6

6.6

147

944

A10AD04

ATC

insulin lispro; parenteral

8.7

6.6

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.0

6.5

327

Z01.9

ICD-10 Finland

Special examination, unspecified

1.8

6.5

513

U07

ICPC

Urine symptom/complaint other

1.7

6.5

119

725

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.4

6.5

189

TPH07

NOMESCO Finland

Cathetrisation of artery

1.6

6.5

156

1018

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.4

6.5

183

N05AB03

ATC

perphenazine; systemic, rectal

2.2

6.5

234

R4180, ,

SPAT

3.1

6.5

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

2.4

6.5

171

WX213

NOMESCO Finland

Lower leg blockade

5.3

6.5

K85

ICPC

Elevated blood pressure

1.5

6.5

247

1780

BC1AD

NOMESCO Finland

CT of adrenal glands

3.5

6.4

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

3.9

6.4

R05

ICD-10 Finland

Cough

1.4

6.4

287

2128

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

3.2

6.4

ZXA05

NOMESCO Finland

Left side

1.4

6.4

343

2623

C09DX04

ATC

valsartan and sacubitril; oral

3.4

6.4

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

2.2

6.4

222

J01FA01

ATC

erythromycin; systemic

1.6

6.4

151

981

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

1.9

6.4

378

V03AE03

ATC

lanthanum carbonate; oral

7.4

6.4

7865A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Chest pain

2.8

6.4

113

A02BX02

ATC

sucralfate; oral

2.1

6.4

282

S20

ICPC

Corn/callosity

2.6

6.4

142

K77

ICPC

Heart failure

2.6

6.4

142

WW200, ,

SPAT

0.7

6.4

288

3786

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

6.4

1014

9055

64090

ICD-8 Finland

Artificial termination of pregnancy performed for medical reasons, Woman's illness or physical defect (medicines. Cause)

4.1

6.4

I20.8

ICD-10 Finland

Other forms of angina pectoris

4.1

6.4

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

8.2

6.3

SPAT1216

SPAT

Assessment of functional ability

1.5

6.3

227

1616

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.6

6.3

148

961

E26.0

ICD-10 Finland

Primary hyperaldosteronism

6.0

6.3

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

6.3

212

1490

R39.1

ICD-10 Finland

Other difficulties with micturition

2.2

6.3

237

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.5

6.3

A08

ICPC

Swelling

1.8

6.3

460

H3601, E106,

ICD-10 Finland

+∞

6.3

R26.2

ICD-10 Finland

Difficulty in walking, not elsewhere classified

3.0

6.2

C07FB02

ATC

metoprolol and felodipine; systemic

2.2

6.2

225

H3601, E116,

ICD-10 Finland

26.8

6.2

M10.3

ICD-10 Finland

Gout due to impairment of renal function

7.0

6.2

FM1TQ

NOMESCO Finland

Heart perfusion SPECT with low dose CT at rest and with exercise

7.0

6.2

N06AX12

ATC

bupropion; oral

1.9

6.2

411

S03CA04

ATC

hydrocortisone and antiinfectives; ophthalmic, otic

2.3

6.2

187

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.9

6.2

412

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

3.2

6.2

SPAT1172

SPAT

Guidance concerning hydration

2.6

6.1

127

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

2.6

6.1

127

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

5.8

6.1

7804A

ICD-9 Finland

General symptoms, Dizziness and giddiness

3.3

6.1

N20.0

ICD-10 Finland

Calculus of kidney

2.5

6.1

145

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

6.1

514

4209

D01AC02

ATC

miconazole; topical

1.7

6.1

115

707

C09DA03

ATC

valsartan and diuretics; oral

1.9

6.1

385

Z13.5

ICD-10 Finland

Special screening examination for eye and ear disorders

4.1

6.1

T83

ICPC

Overweight

2.9

6.1

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

6.7

6.0

E11.09

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - With coma

10.1

6.0

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

10.1

6.0

D07XC01

ATC

betamethasone; topical

1.5

6.0

183

1259

P01

ICPC

Feeling anxious/nervous/tense

1.7

6.0

104

625

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

3.4

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3020682) Albumin/Creatinine [Ratio] in Urine

1016

4907

3.73

150.38

6.2

3.9

19.21

6.24

mg/mmol

6.66

756

3046

(3012516) Albumin [Mass/volume] in Urine

997

4808

3.66

146.81

5.0

3.3

93.37

35.76

mg/l

8.26

762

3079

(3009508) Creatinine [Moles/volume] in Urine

1003

4997

3.52

137.22

5.2

3.3

7.28

7.96

mmol/l

5.35

887

4134

(3020779) Urea [Moles/volume] in Serum or Plasma

358

1268

3.32

79.31

12.1

6.3

12.42

9.96

mmol/l

5.99

344

1212

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

145

260

6.01

78.29

1.6

1.7

1.02

0.84

nmol/l

1.34

122

220

(3003458) Phosphate [Moles/volume] in Serum or Plasma

431

1744

2.98

75.59

10.7

5.3

1.11

1.01

mmol/l

8.24

410

1610

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

801

4519

2.48

71.10

4.2

3.0

2624.33

1319.10

ng/l

4.32

706

3879

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

762

4315

2.41

65.64

3.1

2.1

270.32

249.89

u/l

0.15

723

4087

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

142

312

4.88

60.93

2.5

2.2

193.62

117.43

ug/min

0.64

183

(3012544) pH of Venous blood

354

1444

2.84

59.81

5.4

3.3

7.37

7.38

3.78

242

814

(3026493) Urate [Moles/volume] in Serum or Plasma

681

3792

2.34

59.52

3.7

2.7

383.95

351.08

umol/l

10.41

601

3299

(3002032) Base excess in Venous blood by calculation

343

1398

2.83

57.88

5.5

3.2

1.49

1.93

mmol/l

1.18

299

1226

(3022948) Iron [Moles/volume] in Serum or Plasma

481

2351

2.47

55.85

4.0

2.4

11.70

13.20

umol/l

4.45

451

2202

(3032080) INR in Blood by Coagulation assay

1022

6861

2.26

55.49

21.9

15.7

1.35

1.29

inr

2.20

870

5737

(3004789) Transferrin [Mass/volume] in Serum or Plasma

455

2182

2.49

54.94

3.9

2.4

2.35

2.28

g/l

1.99

426

2020

(3021447) Carbon dioxide [Partial pressure] in Venous blood

345

1448

2.74

54.78

5.4

3.2

5.91

5.83

kpa

0.72

330

1412

(3013826) Glucose [Moles/volume] in Serum or Plasma

1178

8413

2.35

54.72

9.4

4.7

7.87

6.73

mmol/l

34.67

1143

8018

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

432

2040

2.51

53.79

4.0

2.4

19.80

23.44

7.69

410

1904

(3024561) Albumin [Mass/volume] in Serum or Plasma

957

6355

2.18

52.04

6.7

4.9

35.08

35.40

g/l

0.97

901

5906

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

740

4487

2.16

50.33

3.3

3.1

34.25

37.44

u/l

0.68

689

4209

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

636

3640

2.21

50.02

3.0

2.2

3.23

2.94

mg/l

2.38

562

3113

(3024354) Oxygen [Partial pressure] in Venous blood

297

1248

2.68

46.47

4.1

2.5

4.79

4.53

kpa

0.97

279

1219

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

242

924

2.89

45.43

5.1

3.5

127.79

89.89

ng/l

3.85

208

792

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

848

5565

2.06

45.25

6.1

3.5

126.94

60.34

ng/l

0.39

680

4169

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1014

7126

2.07

44.55

12.4

6.6

1.20

1.21

mmol/l

1.62

877

6084

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

144

5.78

42.77

1.4

1.2

1.69

1.49

nmol/l

0.65

131

(3009343) pH of Capillary blood

230

890

2.84

41.96

4.7

3.5

7.41

7.42

1.93

193

745

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

234

919

2.80

41.49

4.8

3.5

5.05

5.16

kpa

1.32

227

890

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1039

7486

2.02

41.10

6.8

6.7

11.35

12.13

umol/l

1.54

987

7150

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

193

4.93

40.54

1.2

1.1

101.52

116.49

iu/ml

0.05

(3027945) Reticulocytes/Erythrocytes in Blood

355

1723

2.35

40.31

3.5

2.6

1.88

1.75

2.08

322

1552

(3012095) Magnesium [Moles/volume] in Serum or Plasma

432

2279

2.21

40.15

3.9

3.3

0.81

0.82

mmol/l

1.15

407

2156

(3020876) Protein [Mass/time] in 24 hour Urine

151

5.37

38.55

2.9

2.4

1.92

1.69

g/24h

0.17

(3036481) Cortisol [Moles/volume] in Serum or Plasma

257

1103

2.57

38.04

2.0

2.3

366.77

369.73

nmol/l

0.08

225

1032

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

277

1234

2.49

37.89

3.0

2.2

7.31

7.90

ug/l

0.16

247

1104

(3000991) Gas panel - Venous blood

273

1213

2.49

37.53

12.8

8.6

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

201

772

2.82

37.00

4.5

3.3

1.22

1.91

mmol/l

1.15

138

586

(3023368) Bacteria identified in Blood by Culture

652

4158

1.93

35.14

6.0

4.3

—

(3044640) Blood type and Crossmatch panel - Blood

691

4503

1.91

34.79

2.8

2.5

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

901

6400

1.88

34.64

2.6

2.1

94.62

95.02

pmol/l

0.10

551

3486

(3022313) Gas panel - Capillary blood

171

641

2.86

32.83

4.8

3.7

—

(3018095) Leukocytes [#/volume] in Urine

765

5236

1.85

32.33

5.8

3.7

73.73

110.97

e6/l

1.11

575

3815

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

169

651

2.78

30.77

1.6

1.9

1.78

1.49

g/l

3.18

149

568

(3002582) Erythrocytes [#/volume] in Urine

700

4728

1.83

30.31

5.2

3.2

52.18

99.86

e6/l

1.33

566

3662

(3001122) Ferritin [Mass/volume] in Serum or Plasma

835

5955

1.80

30.10

4.4

2.8

166.94

156.63

ug/l

0.41

769

5473

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

486

2933

1.93

29.96

1.8

1.6

1.09

1.42

mg/l

2.22

370

2271

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

134

468

3.03

29.16

3.0

2.7

0.45

0.33

iu/ml

1.54

242

(3007853) Bacteria identified in Skin by Aerobe culture

313

1634

2.13

28.86

2.2

1.7

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

134

478

2.96

28.07

2.2

3.7

45.44

44.71

mg/l

0.03

118

411

(3034860) Kappa light chains.free [Mass/volume] in Serum

134

479

2.95

27.97

2.2

3.7

65.15

57.77

mg/l

0.15

118

408

(3020630) Protein [Mass/volume] in Serum or Plasma

256

1253

2.23

27.70

1.9

2.6

66.47

66.59

g/l

0.08

235

1146

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1318

10938

1.97

27.68

10.6

8.1

84.24

79.27

u/l

2.19

1264

10352

(3015377) Calcium [Moles/volume] in Serum or Plasma

708

4903

1.77

27.40

3.7

3.5

2.36

2.35

mmol/l

0.54

653

4413

(3018677) aPTT in Platelet poor plasma by Coagulation assay

373

2113

1.98

27.37

2.2

1.9

30.40

29.83

0.66

367

2050

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

123

426

3.04

27.14

2.1

3.4

2.95

3.36

ratio

0.09

244

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

539

3456

1.83

26.96

2.7

2.4

—

(3000850) Epithelial cells [#/volume] in Urine

521

3312

1.83

26.77

4.3

2.5

4.75

4.66

e6/l

0.06

493

3013

(3019309) Folate [Moles/volume] in Red Blood Cells

423

2523

1.91

26.54

2.0

1.7

1124.02

1161.19

nmol/l

0.34

334

1928

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

869

6417

1.74

26.50

11.9

6.0

1.21

mmol/l

0.21

814

5879

(3042936) Bacteria identified in Isolate by Culture

362

2051

1.98

26.45

2.8

2.0

—

(3019198) Lymphocytes [#/volume] in Blood

954

7241

1.74

26.26

7.4

6.3

1.92

e9/l

0.02

835

6370

(3014111) Lactate [Moles/volume] in Serum or Plasma

258

1295

2.17

26.13

11.4

7.3

1.50

1.37

mmol/l

0.96

252

1274

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

821

5984

1.73

26.10

3.2

2.3

72.62

78.41

nmol/l

7.23

749

5285

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

186

823

2.42

25.35

5.5

3.4

23.84

24.31

mmol/l

1.06

178

814

(3018010) Neutrophils/Leukocytes in Blood

868

6462

1.71

25.23

6.9

6.4

59.39

57.68

4.31

832

6163

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

656

4532

1.74

24.96

3.2

2.5

53.76

62.86

u/l

3.68

613

4170

(3018418) pH of Serum or Plasma

615

4176

1.75

24.87

7.8

3.9

7.39

7.40

0.89

473

3043

(3006315) Basophils [#/volume] in Blood

933

7104

1.71

24.77

7.3

6.2

0.04

e9/l

1.48

807

6087

(3013512) EKG study

743

5325

1.71

24.65

5.1

3.4

—

0.77

—

(3023520) Reticulocytes [#/volume] in Blood

260

1346

2.10

24.21

3.5

2.8

76.99

67.71

e9/l

4.32

204

1007

(3001604) Monocytes [#/volume] in Blood

928

7084

1.70

24.15

7.2

6.2

0.64

0.60

e9/l

4.15

802

6074

(3002030) Lymphocytes/Leukocytes in Blood

877

6603

1.69

23.96

7.3

6.5

25.81

27.06

2.71

839

6236

(3016502) Oxygen saturation in Arterial blood

280

1498

2.04

23.84

11.1

8.2

93.93

95.52

2.53

275

1447

(3015736) pH of Urine

793

5833

1.68

23.51

4.8

3.3

6.22

6.21

0.14

458

3276

(3021960) Folate [Moles/volume] in Serum or Plasma

610

4183

1.72

23.49

1.9

1.7

20.70

19.94

nmol/l

0.32

527

3483

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

472

3028

1.78

22.89

2.1

1.8

21995288.39

33547268.82

pmol/l

0.19

391

2498

(3013115) Eosinophils [#/volume] in Blood

946

7318

1.67

22.87

7.7

6.5

0.21

0.20

e9/l

1.38

822

6372

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

114

419

2.85

22.58

3.8

2.6

2.01

1.56

mg/l

3.84

108

376

(4146454) Self-monitoring of blood glucose

135

4.34

22.18

2.5

2.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

210

1035

2.18

22.09

1.8

2.4

—

(3019069) Monocytes/Leukocytes in Blood

856

6489

1.65

22.09

7.2

6.6

8.83

9.10

2.09

805

6058

(3022096) Basophils/Leukocytes in Blood

852

6479

1.64

21.49

7.3

6.6

0.67

0.68

0.12

797

6037

(3040151) Glucose [Moles/volume] in Capillary blood

140

4.18

21.16

20.6

4.6

8.81

6.74

mmol/l

3.82

118

(3006504) Eosinophils/Leukocytes in Blood

851

6486

1.64

21.14

7.2

6.5

2.85

2.89

0.21

802

6048

(3004775) Volume in Urine collected for unspecified duration

4.86

21.11

2.4

2.2

649.09

658.87

0.05

(3003396) Base excess in Arterial blood by calculation

294

1667

1.93

21.00

11.0

7.9

0.78

0.98

mmol/l

0.34

251

1366

(3026008) Bacteria identified in Urine by Culture

570

3933

1.68

20.89

3.8

3.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

319

3.03

20.85

2.3

2.0

124.70

129.99

g/l

0.92

244

(3031040) Bacteria [#/volume] in Urine by Automated count

1103

8990

1.67

20.80

6.6

4.4

600.00

1908.33

e6/l

1.07

120

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

180

867

2.21

19.99

13.7

9.5

23.84

24.31

mmol/l

1.00

174

850

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

135

579

2.45

19.61

1.5

2.2

8.00

7.20

g/l

5.44

124

530

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

135

579

2.45

19.61

1.5

2.2

4.36

4.18

g/l

1.60

123

532

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

135

579

2.45

19.61

1.5

2.2

3.77

3.79

g/l

0.04

124

531

(3037522) Nuclear Ab [Titer] in Serum

300

1748

1.87

19.61

1.3

414.04

466.35

titre

0.39

375

(3009261) Glucose [Presence] in Urine by Test strip

943

7463

1.60

19.36

5.4

3.7

0.22

0.21

estimate

0.03

173

1518

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

129

552

2.45

18.83

1.6

2.2

2.99

2.93

g/l

0.25

118

505

(3035350) Ketones [Presence] in Urine by Test strip

936

7427

1.59

18.74

5.4

3.7

20.04

0.85

estimate

1.00

206

1624

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

289

1690

1.86

18.60

11.2

7.9

5.09

5.16

kpa

0.50

279

1623

(3027801) Oxygen [Partial pressure] in Arterial blood

289

1691

1.86

18.56

11.2

7.9

11.14

12.22

kpa

3.58

275

1625

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1205

10175

1.66

18.53

5.3

3.8

14.77

14.90

pmol/l

1.09

1107

9151

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

113

4.25

17.96

1.3

1.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

922

7339

1.57

17.82

5.5

3.7

0.00

estimate

-0.00

202

1596

(3007164) IgA [Mass/volume] in Serum or Plasma

384

2470

1.72

17.81

1.5

2.74

2.67

g/l

0.27

249

1523

(3013650) Neutrophils [#/volume] in Blood by Automated count

988

7997

1.58

17.69

10.6

9.6

4.62

4.17

e9/l

6.96

874

6937

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

295

1766

1.81

17.52

3.9

4.7

242.73

244.71

u/l

0.09

273

1687

(3033658) Prothrombin time (PT) actual/Normal

500

3460

1.63

17.50

5.8

4.0

86.96

86.31

0.20

483

3394

(3027923) C peptide [Moles/volume] in Serum or Plasma

5.02

17.39

1.2

1.3

1.22

1.17

nmol/l

0.08

(40760888) Immunoglobulin light chains.free panel - Serum

319

2.82

17.32

1.8

4.1

—

(3024928) Oxygen saturation in Venous blood

349

2.73

17.17

3.6

2.4

60.34

61.23

0.13

339

(3037121) Protein [Mass/volume] in Urine

112

469

2.49

17.12

3.9

3.1

520.81

409.24

mg/l

0.31

192

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

827

6460

1.55

17.10

3.2

2.7

—

estimate

—

(1616796) Gas panel - Central venous blood

299

2.87

17.07

5.3

3.5

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

249

1425

1.88

17.06

2.0

2.3

0.22

0.21

g/l

1.48

227

1336

(3051387) C reactive protein [Mass/volume] in Capillary blood

296

2.86

16.80

7.0

3.2

27.52

28.75

mg/l

0.12

194

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

117

506

2.41

16.68

5.0

3.6

23.73

24.94

mmol/l

3.85

111

481

(3007566) Smooth muscle Ab [Titer] in Serum

368

2.65

16.50

1.1

1.2

376.25

116.18

titre

—

(3028026) IgM [Mass/volume] in Serum or Plasma

163

814

2.11

16.45

1.4

2.0

1.07

1.53

g/l

2.93

149

741

(3019977) pH of Arterial blood

280

1685

1.79

16.26

11.4

8.0

7.41

0.13

157

949

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

367

2407

1.67

15.59

2.2

1.9

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

160

813

2.07

15.41

3.6

2.2

1.42

1.22

1.29

160

808

(3030467) Casts [#/volume] in Urine by Automated count

560

4090

1.55

15.16

5.1

3.1

0.32

0.45

e6/l

1.50

437

3052

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

114

509

2.33

15.13

1.6

2.2

9.36

10.61

g/l

3.26

102

457

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1457

13169

1.82

15.10

13.2

6.2

47.01

39.23

mmol/mol

92.53

1384

12175

(3026782) Osmolality of Urine

402

2719

1.63

15.07

4.3

2.7

538.63

552.18

mosm/kgh2o

0.53

367

2372

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1390

12400

1.72

15.04

6.9

4.7

2.02

1.98

mu/l

0.53

1303

11246

(3011985) Renin [Units/volume] in Plasma

148

3.52

15.03

2.0

1.3

76.83

105.39

mu/l

0.24

131

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

395

2669

1.63

14.84

5.1

3.7

331.19

888.88

ng/l

0.91

332

2165

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

114

515

2.30

14.72

1.6

2.4

0.31

1.34

g/l

3.95

101

441

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

130

623

2.18

14.56

2.1

1.9

4.24

2.46

ug/l

0.68

119

553

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

164

861

2.00

14.42

1.8

1.6

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1077

9093

1.52

14.33

4.4

3.2

75.06

51.43

u/l

8.07

991

8485

(3021589) Normoblasts [#/volume] in Blood

782

6228

1.48

13.58

16.0

11.3

0.01

0.00

e9/l

0.46

643

5124

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

129

636

2.11

13.44

2.9

3.4

4.17

4.47

pmol/l

2.97

113

566

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

347

2.50

13.24

1.4

1.2

7.72

5.92

iu/ml

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

221

1314

1.79

13.22

2.0

1.5

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1478

13528

1.79

13.16

27.7

15.4

25.03

26.00

mg/l

0.50

1332

11116

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

1186

10299

1.52

13.15

5.4

4.3

15.39

12.16

mm/h

8.95

1103

9560

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

416

2923

1.56

13.03

3.1

2.47

2.45

mmol/l

1.59

376

2641

(3022621) pH of Urine by Test strip

189

1080

1.85

12.87

3.1

2.5

5.92

6.04

0.97

147

739

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

245

1514

1.72

12.79

1.9

1.5

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

135

3.40

12.64

1.6

1.3

297.49

305.81

pmol/l

0.06

116

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

250

1560

1.71

12.59

4.7

3.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

136

3.37

12.50

1.2

1.4

—

nmol/l

—

(1761482) Bacteria [#/volume] in Urine by Culture

340

2.45

12.36

4.0

4.4

—

(40768797) Stomach Pathology biopsy report

294

1924

1.64

12.33

1.3

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

103

482

2.21

12.25

1.3

1.2

—

(42870588) Differential panel, method unspecified - Blood

612

4713

1.47

12.23

6.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

430

2.28

12.23

1.7

2.2

0.00

g/l

-0.00

378

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

138

3.32

12.22

1.3

1.4

1.00

0.19

nmol/l

0.48

111

(3016750) Collection duration of Urine

4.31

12.22

2.5

2.0

514.05

499.72

min

0.29

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

395

2784

1.55

12.08

1.3

1.2

1.44

1.58

u/ml

0.15

119

742

(3023183) Ammonium ion [Moles/volume] in Plasma

302

2.52

11.99

2.6

2.7

34.26

35.44

umol/l

0.14

273

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

168

948

1.86

11.89

1.8

1.6

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

322

2.46

11.85

1.6

1.3

8.36

7.88

u/l

0.16

261

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

438

2.24

11.72

1.7

2.2

0.00

0.02

g/l

1.44

395

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

271

1761

1.64

11.65

2.0

1.7

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

4.26

11.29

2.6

2.0

191.56

125.26

ug/min

—

(3005719) IgG [Mass/volume] in Serum or Plasma

181

1069

1.78

11.02

2.0

2.9

10.27

10.84

g/l

0.95

171

985

(44816559) Phosphatidylethanol [Mass/volume] in Blood

109

544

2.07

11.01

1.8

1.7

0.37

0.33

mg/l

0.34

255

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1416

12946

1.61

11.00

7.6

4.2

2.36

1.27

mmol/l

56.60

1326

11785

(3000330) Specific gravity of Urine by Test strip

130

693

1.95

10.93

4.3

3.4

1.02

ratio

0.64

122

630

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

187

1119

1.76

10.88

3.2

2.8

354.59

206.08

ng/l

1.75

169

1020

(3003181) Sodium [Moles/volume] in Urine

138

3.17

10.88

1.4

1.2

55.70

69.63

mmol/l

1.77

108

(3021440) Promyelocytes/Leukocytes in Blood

207

1277

1.71

10.81

4.8

4.6

0.07

0.10

0.59

362

(46235355) HIV 1 and 2 tests - Meaningful Use set

268

1772

1.61

10.68

2.2

1.7

—

(3017181) Myelocytes/Leukocytes in Blood

214

1337

1.69

10.66

4.7

4.5

0.95

0.88

0.11

420

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

107

537

2.06

10.66

2.0

1.8

—

(3010838) Calcium [Moles/time] in 24 hour Urine

178

2.86

10.59

2.0

1.8

3.65

4.76

mmol/24h

1.67

161

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

134

733

1.90

10.44

1.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

245

1595

1.63

10.39

2.1

1.8

1.51

1.50

0.06

220

1390

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

354

2512

1.52

10.31

4.5

2.9

1.36

0.99

e6/l

0.90

215

1391

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

235

1517

1.64

10.31

2.5

2.7

8.92

8.73

umol/l

0.06

195

1357

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

191

1169

1.72

10.25

8.2

3.4

1.21

1.23

mmol/l

1.53

169

1004

(21494890) Protein electrophoresis panel - 24 hour Urine

145

3.02

10.04

1.7

2.0

—

(3002179) Metamyelocytes/Leukocytes in Blood

204

1280

1.68

9.98

4.3

4.4

1.04

0.68

0.54

398

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

186

2.74

9.78

1.1

1.0

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

393

2.17

9.63

1.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

149

2.94

9.58

1.3

1.4

26.17

25.02

ng/l

0.08

149

(3025941) Bacteria identified in Stool by Culture

119

645

1.91

9.54

1.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

111

589

1.95

9.48

2.2

1.9

—

(3002079) Sodium [Moles/time] in 24 hour Urine

5.18

9.37

1.2

1.6

190.37

158.83

mmol/24h

0.56

(40760892) CBC W Ordered Manual Differential panel - Blood

416

3104

1.45

9.32

6.4

4.8

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

316

2243

1.50

9.09

4.5

3.1

2.30

1.75

e6/l

0.58

169

1115

(3029937) Albumin [Presence] in Urine by Test strip

553

4366

1.40

8.98

5.7

3.8

0.00

estimate

0.50

157

1451

(3019060) Gas panel - Arterial blood

149

883

1.75

8.96

5.0

5.2

—

(3020891) Body temperature

130

740

1.82

8.95

6.1

4.2

36.93

36.90

°c

0.33

130

734

(3000570) Elastase.pancreatic [Mass/mass] in Stool

399

2.11

8.90

1.6

1.5

277.40

263.49

ug/g

0.24

241

(3025159) Blasts/Leukocytes in Blood

200

1289

1.63

8.79

5.1

4.9

0.08

0.14

0.56

346

(3012501) Base excess in Blood by calculation

290

2.29

8.73

6.0

3.9

2.48

2.62

mmol/l

0.14

192

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

241

1628

1.56

8.68

2.0

1.8

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

286

2.29

8.57

1.2

1.3

20.67

45.47

u/l

1.31

245

(3024471) HLA-A [Type]

4.49

8.37

1.0

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

193

1250

1.61

8.31

2.6

164.75

40.40

u/l

0.48

165

1063

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

190

1226

1.62

8.30

3.0

2.7

51.34

65.55

ml/min/173m2

6.78

487

(3019225) pH of Specimen

218

1463

1.56

8.07

6.8

3.7

7.36

7.34

0.56

178

1036

(3011397) Hemoglobin [Presence] in Urine by Test strip

429

3302

1.40

7.91

4.6

3.6

0.25

0.05

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

682

5663

1.34

7.79

5.7

3.7

0.60

0.03

estimate

0.49

173

1326

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

353

2.09

7.69

1.5

1.6

—

(3017732) Neutrophils [#/volume] in Blood

252

1769

1.50

7.56

3.2

3.3

4.72

4.42

e9/l

0.65

219

1525

(3024932) HLA-DR beta [Type]

4.26

7.48

1.0

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1432

13376

1.49

7.46

7.9

5.1

6.91

5.97

mmol/l

59.91

1325

12124

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1442

13509

1.49

7.19

8.5

5.0

1.16

1.43

mmol/l

140.70

1365

12399

(3022145) Colonoscopy Study observation

230

1602

1.51

7.16

1.5

1.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

3.29

7.12

2.3

2.4

10.67

7.95

mmol/l

2.70

(3019550) Sodium [Moles/volume] in Serum or Plasma

1503

14210

1.57

7.11

35.6

18.0

139.49

139.81

mmol/l

5.52

1486

13918

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

345

2.04

7.02

1.5

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

246

2.23

6.96

1.5

1.2

249.63

282.05

u/ml

0.40

141

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

298

2198

1.43

6.90

1.3

9.81

10.94

u/ml

0.11

126

860

(3048929) Epstein Barr virus Ab [Presence] in Serum

356

2.01

6.81

1.4

1.2

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

1430

13406

1.46

6.79

28.0

15.0

73.48

78.67

ml/min/173m2

12.78

1375

12504

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

314

2346

1.42

6.76

1.3

44.87

36.36

iu/ml

0.39

718

(3041096) Erythrocytes [Presence] in Urine by Automated

487

3910

1.35

6.74

5.3

3.1

0.17

0.04

estimate

0.74

161

1243

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

263

2.17

6.72

1.7

1.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1469

13853

1.50

6.68

9.4

5.7

2.31

2.70

mmol/l

43.72

1399

12730

(3021387) Prolactin [Units/volume] in Serum or Plasma

297

2.09

6.68

1.5

1.6

280.45

281.21

mu/l

0.01

276

(3023103) Potassium [Moles/volume] in Serum or Plasma

1503

14249

1.54

6.58

36.1

18.2

4.03

4.00

mmol/l

5.92

1484

13935

(3000494) Fungus identified in Specimen by Culture

241

1723

1.47

6.57

1.6

1.5

—

(40768446) Kidney Pathology biopsy report

4.18

6.55

2.5

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

3.67

6.48

1.7

2.1

92.33

74.08

umol/l

—

(3014051) Protein [Presence] in Urine by Test strip

452

3613

1.34

6.39

3.9

2.8

0.11

0.02

0.37

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1445

13610

1.45

6.34

8.5

5.1

4.28

4.59

mmol/l

18.72

1372

12582

(3042733) HLA Ab [Presence] in Serum

3.98

6.17

5.1

5.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

3.23

6.15

1.3

1.8

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

838

7336

1.29

5.96

2.7

2.5

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

551

1.75

5.93

1.9

34.69

39.26

u/l

1.27

481

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

101

2.80

5.90

1.2

1.3

19.88

27.85

u/l

0.65

(3027456) Digoxin [Moles/volume] in Serum or Plasma

300

2.00

5.79

2.9

3.3

0.89

0.80

nmol/l

1.02

248

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

241

2.06

5.29

1.7

1.4

157.39

159.98

au/ml

0.05

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

242

2.06

5.23

1.3

1.2

—

(3004451) EKG impression Narrative

2.96

5.15

1.2

1.3

—

(3004809) Band form neutrophils/Leukocytes in Blood

258

2.01

5.11

4.2

4.0

1.57

0.00

232

(3038026) Centromere Ab [Units/volume] in Serum

122

2.49

5.05

1.1

1.2

—

51.76

—

(3045414) Leukocytes [Presence] in Urine

201

1460

1.43

5.02

2.5

1.9

0.00

0.02

estimate

0.78

286

(3004616) Nuclear Ab [Presence] in Serum

179

2.21

5.02

1.2

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

678

5868

1.26

4.99

2.3

1.9

2.61

1.33

mmol/l

23.39

553

4804

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

261

1.98

4.96

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

261

1.98

4.96

1.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

421

1.77

4.92

2.8

1.6

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

2.68

4.92

1.8

1.5

122.60

85.97

umol/l

1.57

(3037756) Immunofixation for Serum or Plasma

319

1.88

4.89

1.2

1.6

—

(3020491) Glucose [Moles/volume] in Blood

101

2.60

4.81

1.5

2.2

6.85

mmol/l

0.00

(3006922) Hepatitis E virus Ab [Presence] in Serum

2.69

4.75

1.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

245

1861

1.37

4.71

10.3

6.4

—

(40768804) Tissue Pathology biopsy report

638

5511

1.25

4.70

2.5

2.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

2.73

4.68

1.1

95.65

108.61

pmol/l

0.51

(3000012) Reticulocyte production index

225

2.03

4.68

2.2

2.4

0.93

0.91

0.09

164

(3022493) Free Hemoglobin [Mass/volume] in Plasma

3.04

4.67

1.1

3.0

48.31

53.89

mg/l

0.22

(3020911) Cortisol [Moles/time] in 24 hour Urine

4.55

4.56

1.5

1.4

56.00

282.32

nmol/24h

0.56

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

123

2.38

4.50

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

287

1.87

4.41

7.3

5.0

398.17

345.10

iu/ml

0.08

(4024509) Urine culture

616

1.59

4.37

2.2

1.9

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

369

1.76

4.35

1.7

2.2

209.33

193.27

0.59

350

(3048689) Calprotectin [Mass/mass] in Stool

206

1542

1.38

4.34

2.4

2.5

157.72

143.29

ug/g

0.29

164

1226

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.64

4.23

3.5

1.9

221.96

137.93

ng/l

1.10

(3020191) Ethanol [Moles/volume] in Serum or Plasma

2.52

4.22

1.5

1.3

1.54

1.13

promille

0.63

(3007930) Methemoglobin/Hemoglobin.total in Blood

566

1.60

4.21

4.7

6.0

0.83

0.87

0.34

528

(4198724) Urine methamphetamine measurement

3.44

4.19

2.8

1.7

—

(4035726) Immunohistochemistry procedure

172

1261

1.41

4.10

1.3

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

142

2.21

4.06

11.9

2.2

—

(21494755) Public health laboratory ask at order entry panel

1070

0.60

4.05

1.3

1.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

244

1898

1.33

4.02

7.4

4.7

27.83

32.45

10.09

193

1203

(3052851) Hemolysis interference index of Serum or Plasma

357

1.74

3.97

3.7

3.4

1.35

2.04

index

0.62

182

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

171

2.07

3.92

1.2

1.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

119

2.29

3.88

1.4

2.0

3.06

1.45

u/field

0.67

(3005988) Vibrio sp identified in Specimen by Organism specific culture

172

2.06

3.86

1.2

1.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

360

1.72

3.86

2.2

2.1

11.69

11.78

mg/l

0.02

339

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

2.79

3.86

2.7

2.5

240.83

195.35

u/l

1.72

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.31

3.82

3.1

1.9

8.39

9.34

kpa

1.06

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.31

3.82

3.1

1.9

5.29

5.17

kpa

0.08

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1336

0.66

3.76

2.3

2.2

5.08

3.59

ratio

1.21

1084

(3005570) Glucose [Moles/volume] in Urine

135

2.17

3.68

1.7

1.9

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

163

2.05

3.61

4.7

4.5

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

2.96

3.57

3.1

2.0

280.80

740.18

e6/l

—

(3018572) Chloride [Moles/volume] in Blood

266

0.33

3.56

17.1

8.6

104.67

105.46

mmol/l

—

229

(3039000) Anion gap in Blood by calculation

266

0.33

3.56

17.1

8.5

10.56

11.27

mmol/l

—

229

(3025468) Yersinia sp identified in Specimen by Organism specific culture

171

2.01

3.55

1.2

1.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

4.25

3.50

1.2

1.1

1.17

1.18

mmol/l

0.03

(3017354) Segmented neutrophils/Leukocytes in Blood

186

1.96

3.49

2.4

4.1

60.48

56.82

0.51

162

(3032773) Endomysium IgG Ab [Titer] in Serum

112

2.25

3.49

1.2

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

304

1.73

3.44

1.9

1.7

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

4.57

3.43

2.2

1.5

114.30

125.50

ug/l

—

(3019150) Specific gravity of Urine by Refractometry

389

3292

1.24

3.26

5.9

3.8

1.02

kg/l

0.17

290

2116

(3023420) DNA double strand Ab [Units/volume] in Serum

538

1.53

3.24

1.6

1.8

8.04

7.28

iu/ml

0.09

128

(3021879) Hepatitis B virus core Ab [Presence] in Serum

124

897

1.41

3.23

1.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

104

729

1.45

3.21

1.2

47.72

142.67

u/ml

5.21

258

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

2.87

3.19

1.0

1.8

38.22

40.60

g/l

0.79

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

179

1.92

3.15

1.2

1.4

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

201

1.86

3.13

1.1

—

4.00

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.48

3.13

1.0

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.55

3.13

1.0

1.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

275

1.73

3.12

1.9

1.8

4.80

4.01

iu/l

0.17

103

(3044927) Protein electrophoresis panel - Urine

145

2.02

3.11

1.2

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

368

1.63

3.10

1.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.82

3.09

1.1

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

219

1742

1.30

3.08

1.7

1.4

—

(3049717) Cytology report of Urine Cyto stain

652

1.47

3.08

3.4

2.7

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

217

1.82

3.07

1.2

1.3

—

(3002256) Pathology report gross observation

245

1981

1.28

3.04

1.5

1.3

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

2.36

2.99

1.1

1.0

—

(3036489) Thrombin time

485

1.53

2.95

1.7

1.9

22.12

21.04

0.28

440

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

177

1.88

2.92

1.2

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

259

1.72

2.88

8.6

1.8

—

(3051101) Glucose [Moles/volume] in Cord blood

3.72

2.88

5.1

6.1

8.56

8.63

mmol/l

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

116

2.08

2.83

1.0

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

179

1.86

2.83

1.2

1.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

165

1.90

2.81

1.5

1.4

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

418

1.55

2.80

1.6

1.47

0.18

iu/ml

0.42

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

4.46

2.79

7.6

9.6

7.15

5.73

mmol/l

—

(3033099) Centromere Ab [Titer] in Serum

3.59

2.78

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

117

2.07

2.77

1.3

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.44

2.71

1.0

1.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

342

1.60

2.70

1.6

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

133

1.97

2.66

1.2

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

2.80

2.65

3.5

1.7

983.00

35021.75

e6/l

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.56

2.61

1.0

1.6

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.56

2.61

1.0

1.6

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

148

1.91

2.61

1.8

1.4

24.94

25.07

0.01

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

145

1118

1.33

2.58

1.6

1.4

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

949

0.67

2.57

2.1

1.9

3.50

3.51

mmol/l

0.03

700

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

7.16

2.55

1.0

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

7.16

2.55

1.0

1.3

1.87

2.09

umol/24h

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

2.61

2.53

7.9

6.8

6.46

13.51

ug/l

—

(3035715) Granulocytes [#/volume] in Blood

249

1.66

2.44

3.1

3.3

4.38

4.37

e9/l

0.00

249

(3017569) Oxygen content in Arterial blood

2.18

2.41

2.4

2.9

16.12

16.30

0.09

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

110

2.01

2.41

1.4

1.5

0.15

0.23

nmol/l

1.51

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

197

1.74

2.40

1.8

1.5

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

200

1629

1.26

2.36

3.7

2.3

11.75

14.10

nmol/l

4.81

178

1496

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

118

1.96

2.36

1.3

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

206

1.71

2.35

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.32

2.31

1.9

2.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

223

1.67

2.28

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

350

1.53

2.26

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

351

1.53

2.24

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

303

1.57

2.23

2.9

1.9

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

352

1.52

2.21

1.1

—

(3001729) Color of Synovial fluid

5.57

2.21

2.0

1.3

—

(40758558) Short blood count panel - Blood

466

4149

1.17

2.18

7.6

6.1

—

(3011288) Drugs identified in Urine by Screen method Nominal

211

1.67

2.17

13.8

2.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

137

1.84

2.14

2.0

2.1

92.08

3626.17

u/l

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

267

1.59

2.13

1.9

1.7

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

533

1.41

2.07

1.2

1.3

—

(1761868) Lipid panel - Serum or Plasma

573

5202

1.15

2.06

5.6

3.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

2.41

2.02

1.9

1.8

2.04

12.60

nmol/l

0.68

(3032057) Clostridioides difficile [Presence] in Stool

3.09

2.01

1.9

1.8

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

563

1.39

1.98

2.2

2.8

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1506

14698

1.25

1.98

37.8

20.3

97.85

80.80

umol/l

18.32

1496

14520

(3000764) Benzodiazepines [Presence] in Urine

329

1.50

1.97

8.1

1.8

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

4.56

1.94

1.0

—

(3027008) Opiates [Presence] in Urine

331

1.49

1.93

8.1

1.8

—

(3028300) Cannabinoids [Presence] in Urine

331

1.49

1.93

8.2

1.8

—

(3017704) Immunofixation for Urine

2.06

1.91

1.1

1.5

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

173

1.69

1.90

1.6

73.16

59.74

1.26

110

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

334

1.48

1.85

1.3

—

(3027944) Amphetamines [Presence] in Urine

327

1.48

1.83

3.9

1.8

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

478

1.40

1.82

1.1

1.2

0.16

1.28

u/ml

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1487

14516

1.22

1.80

18.1

11.8

30.19

27.21

u/l

6.17

1449

14043

(3022689) Creatine [Moles/volume] in Urine

2.58

1.80

1.4

1.3

9.41

9.01

mmol/l

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.77

1.79

1.4

1.1

—

(3024263) Appearance of Synovial fluid

2.04

1.75

1.4

1.6

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

3.17

1.66

2.0

2.1

21.13

16.97

umol/l

—

(40768443) Skin Pathology biopsy report

643

1.32

1.66

1.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

196

1.59

1.66

1.5

1.4

600.52

1840.94

e6/l

3.57

144

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.81

1.65

1.6

1.2

—

(3006270) Folate [Moles/volume] in Blood

1.85

1.62

1.3

1.1

384.23

361.21

nmol/l

0.17

(43055514) Macroprolactin [Presence] in Serum or Plasma

3.58

1.61

1.0

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

183

1543

1.21

1.61

3.6

4.5

101.18

29.45

ug/l

0.53

149

1285

(3025018) Bordetella pertussis Ab [Titer] in Serum

2.07

1.60

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

1.96

1.59

1.3

1.2

137.13

140.13

nmol/l

0.10

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.70

1.58

2.3

2.6

4.71

1220.46

ug/l

—

(40768441) Liver Pathology biopsy report

1.86

1.56

1.1

1.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

1.86

1.56

5.6

5.0

70.12

54.42

u/ml

—

(3016879) Cocaine [Presence] in Urine

306

1.45

1.55

8.9

1.8

—

(3047181) Lactate [Moles/volume] in Blood

391

1.39

1.53

4.4

6.8

1.68

1.30

mmol/l

1.02

335

(3028308) Erythrocytes [#/volume] in Pleural fluid

177

1.59

1.52

1.5

1.4

43852.65

67818.08

e6/l

0.19

106

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

283

1.46

1.50

1.6

1.5

—

(3035933) Granulocytes/Leukocytes in Blood

300

1.44

1.50

3.3

3.2

58.19

58.27

0.02

300

(3000475) Leukocytes [#/volume] in Synovial fluid

385

1.39

1.48

1.9

1.6

11694.92

12095.44

e6/l

0.04

270

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

132

1.68

1.46

1.8

1.5

138.02

251.90

pmol/l

0.79

132

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

181

1.56

1.40

1.8

1.6

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.26

1.40

2.7

2.5

0.55

0.62

mmol/l

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

383

4216

0.88

1.39

3.4

3.3

1.02

0.78

ug/l

0.89

266

2793

(3051611) Lipemic interference index of Serum or Plasma

134

1.65

1.39

3.9

2.7

16.08

11.04

index

0.65

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.08

1.38

2.4

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

239

1.47

1.37

1.3

1.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

443

1.34

1.37

1.6

20.64

17.34

u/ml

0.19

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.95

1.36

1.0

1.1

0.02

u/ml

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.95

1.36

1.4

1.0

176.56

95.32

ng/l

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

2.13

1.33

1.2

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

1152

11112

1.12

1.33

35.0

20.0

330.74

332.70

g/l

9.33

1147

11039

(36660697) Celiac disease serology panel - Serum

115

947

1.23

1.32

1.2

—

(4281824) Cell count and differential, peritoneal fluid

121

1.66

1.31

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

193

0.52

1.29

1.5

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.36

1.29

2.8

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

2.78

1.28

1.2

1.4

58.80

69.06

ug/l

—

(3034988) Calcium [Moles/volume] in Capillary blood

2.78

1.28

1.2

1.4

1.16

1.18

mmol/l

—

(3039443) Prostate specific Ag panel - Serum or Plasma

412

0.67

1.27

1.4

1.7

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

162

1.55

1.26

3.5

3.9

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

262

1.42

1.23

1.1

1.6

—

(3044007) Cell count panel - Peritoneal fluid

2.01

1.23

3.9

1.6

—

(40761536) Microorganisms panel - Urine sediment

139

1176

1.20

1.23

5.9

3.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.97

1.22

1.3

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

288

1.40

1.22

1.3

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.05

1.22

1.0

—

(3014891) Appearance of Pleural fluid

2.64

1.21

1.4

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

331

1.37

1.21

1.6

1.5

—

(44806420) Estimation of glomerular filtration rate

132

1.60

1.20

3.4

2.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

307

1.38

1.18

1.1

—

(3045424) Erythrocytes [Presence] in Urine

787

1.23

1.17

2.6

2.0

0.00

1.07

estimate

0.50

234

(3023323) Follitropin [Units/volume] in Serum or Plasma

317

1.37

1.15

1.4

1.3

17.25

27.22

iu/l

2.03

263

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

110

1.64

1.15

1.3

1.4

18.20

19.26

u/ml

—

(3002619) Bacteria identified in Specimen by Culture

2.26

1.10

1.3

1.2

—

(4062490) Immunoglobulin typing, IgG

128

1.57

1.08

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

219

1.42

1.07

1.2

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

374

1.32

1.07

1.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

670

1.24

1.05

2.0

1.6

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

716

1.23

1.04

2.6

2.3

—

(3028433) Virus identified in Specimen by Culture

1.88

1.00

1.4

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.00

1.00

1.0

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

131

1.53

1.00

1.2

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.84

0.98

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.18

0.98

1.8

2.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.18

0.98

1.8

2.2

—

(3023419) Bacteria identified in Sputum by Culture

224

0.62

0.98

2.4

—

(44813793) Dust mix specific IgE antibody measurement

1.67

0.98

1.0

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

389

1.29

0.97

1.8

1.7

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

258

1.36

0.97

3.4

1.9

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

132

1.52

0.97

1.3

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

132

1.52

0.97

1.3

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

132

1.52

0.97

1.3

1.7

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

124

1.54

0.97

3.8

2.5

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.23

0.93

21.8

8.8

6.73

4.89

kpa

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

1.72

0.92

1.2

1.3

11.34

26.18

umol/l

2.97

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.72

0.92

1.3

1.2

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

2.15

0.91

1.0

4.1

—

(3023410) Appearance of Cerebral spinal fluid

127

1.50

0.88

1.8

1.4

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.86

0.87

2.4

1.8

—

(3003327) Ova and parasites identified in Stool by Light microscopy

396

1.27

0.87

1.9

1.6

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.00

0.87

1.5

1.1

—

(3000492) Spirometry study

153

1350

1.15

0.86

1.6

1.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

528

5585

0.92

0.86

4.8

4.5

24.48

21.73

3.65

268

2862

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

727

6955

1.08

0.84

5.2

5.6

2.41

2.98

ug/l

0.94

648

6293

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

416

1.26

0.84

1.7

1.4

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.76

0.83

1.2

421.07

222.41

iu/ml

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.74

0.82

1.3

1.1

—

(3000285) Sodium [Moles/volume] in Blood

1.88

0.82

1.2

1.1

136.50

139.13

mmol/l

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.82

0.79

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

156

1.42

0.79

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

192

1.36

0.75

3.2

2.4

27.94

17.90

mg/l

0.64

(3006462) Nitrate [Presence] in Urine

1.67

0.74

1.8

3.4

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

100

1.50

0.73

1.7

1.4

—

235.71

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

237

1.31

0.72

1.5

—

(3007461) Platelets [#/volume] in Blood

1508

14900

1.12

0.72

42.5

23.6

243.22

242.00

e9/l

0.28

1480

14588

(3014271) Vancomycin [Susceptibility]

1.58

0.71

2.6

2.9

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

1508

14903

1.12

0.70

42.3

23.5

91.24

91.47

1.05

1495

14708

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

126

1.43

0.70

1.1

1.3

—

(3035941) MCH [Entitic mass]

1508

14904

1.12

0.70

42.2

23.4

30.21

30.48

6.66

1495

14707

(3026361) Erythrocytes [#/volume] in Blood

1508

14905

1.12

0.69

42.4

23.5

4.48

4.52

e12/l

1.60

1475

14536

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

1508

14905

1.12

0.69

43.5

24.0

40.03

40.72

4.20

1495

14699

(3010813) Leukocytes [#/volume] in Blood

1508

14906

1.12

0.69

42.5

23.5

7.36

6.72

e9/l

27.06

1475

14540

(3000963) Hemoglobin [Mass/volume] in Blood

1508

14907

1.12

0.68

42.7

23.7

133.99

136.78

g/l

8.57

1494

14716

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

1.58

0.65

1.2

1.05

1.08

ratio

0.58

(40768795) Lymph node Pathology biopsy report

153

0.65

0.62

1.2

—

(3003694) ABO and Rh group [Type] in Blood

408

3863

1.07

0.61

1.4

1.3

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.67

0.61

1.0

4.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

130

1.39

0.61

1.1

1.3

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

1127

11032

1.07

0.60

33.7

19.0

14.11

13.69

17.04

1118

10862

(4094501) Cardiovascular stress test using bicycle ergometer

427

1.20

0.59

1.1

—

(40768806) Pleura Pathology biopsy report

175

1.32

0.58

1.6

1.5

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

1.48

0.57

1.4

26.38

26.48

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.67

0.56

1.5

1.3

11.25

7.98

ug/l

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

813

1.14

0.56

2.1

1.9

—

(3016018) Differential panel - Cerebral spinal fluid

141

1.35

0.56

1.8

1.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.51

0.56

1.5

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.51

0.56

9.5

2.8

0.45

1.08

1.00

(4211845) Urine protein measurement

1.50

0.54

1.8

3.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.49

0.53

1.0

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.49

0.53

1.0

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.49

0.53

1.0

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.49

0.53

1.0

2.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.45

0.53

2.8

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

742

1.14

0.53

2.1

1.8

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

196

1.28

0.52

1.1

1.2

1.87

5.54

u/ml

1.23

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

282

0.78

0.52

1.7

1.4

—

(3045788) Cell count panel - Pleural fluid

161

1.31

0.52

1.6

1.4

—

(3018333) Ribosomal P Ab [Presence] in Serum

1.45

0.51

1.3

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

594

1.15

0.50

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.47

0.50

1.3

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

548

1.16

0.50

2.5

3.6

32.14

2485.62

u/ml

0.76

471

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

110

1214

0.90

0.48

1.4

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

1.41

0.47

1.6

1.5

13.67

5.71

u/l

1.01

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.46

0.46

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.46

0.46

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.46

0.46

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.46

0.46

1.0

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

101

913

1.11

0.46

1.2

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

0.62

0.46

1.2

—

(3045142) Bone marrow Pathology biopsy report

174

1.27

0.45

1.3

1.4

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1.40

0.44

1.3

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

238

1.22

0.44

1.1

—

0.99

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1.38

0.42

1.4

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

158

1.27

0.41

1.2

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.43

0.41

1.8

1.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.52

0.41

2.2

1.4

—

(3042631) Mycobacterium sp identified in Specimen

231

1.22

0.41

2.2

2.6

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.41

0.0

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.41

0.0

1.0

—

(3009015) Lactate [Moles/volume] in Synovial fluid

0.00

0.41

0.0

1.3

—

5.30

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.7

—

54.33

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

0.00

0.41

0.0

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

0.00

0.41

0.0

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

0.00

0.41

0.0

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

0.40

0.0

1.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.31

0.39

1.0

1937.75

1317.26

miu/ml

—

(3015956) Eosinophils/Leukocytes in Blood by Manual count

0.00

0.39

0.0

4.2

—

1.76

—

(40768800) Prostate Pathology biopsy report

463

0.86

0.39

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.37

0.38

1.1

1.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.33

0.37

1.2

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

1.39

0.37

1.1

1.5

8.80

7.36

umol/l

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

191

0.78

0.36

1.1

0.52

1.71

u/ml

—

108

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

207

1.21

0.36

1.1

1.2

1.89

4.32

u/ml

—

(3047189) Immunofixation for 24 hour Urine

1.27

0.36

1.2

1.6

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1.34

0.35

1.4

1.1

—

(4195642) Thrombophilia screening test

162

1.24

0.35

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

162

1.24

0.35

2.1

1.9

—

(37208534) Antinuclear antibody arbitrary concentration in serum

1.43

0.35

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

172

1.22

0.34

1.3

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1.32

0.33

1.4

1.1

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

1.32

0.33

2.6

1.7

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1.32

0.33

1.4

1.1

—

(21494434) Karyotype in Bone marrow

145

1.24

0.33

1.0

1.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

495

0.89

0.31

1.3

1.7

—

(1175426) CD3 cells/Lymphocytes in Blood

0.72

0.31

1.9

2.2

77.14

69.70

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

296

1.15

0.30

1.6

1.3

21.71

39.90

e6/l

0.34

228

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

1.30

0.30

1.0

1.1

—

3.31

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

102

1.28

0.30

1.2

1.5

—

(21494815) CD4 cells/Lymphocytes in Specimen

102

1.28

0.30

1.2

2.3

41.75

38.38

0.33

102

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.29

0.30

1.4

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.25

0.29

1.3

1.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

1.23

0.29

1.7

2.4

128.43

142.20

nmol/l

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

299

1.14

0.27

1.6

1.4

1544.32

844.07

e6/l

0.30

240

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

116

0.77

0.27

1.4

14.78

13.91

u/l

—

109

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.19

0.26

1.1

1.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.28

0.26

1.4

1.2

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

1.25

0.25

1.1

1.3

30.67

27.78

umol/l

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

151

1.19

0.25

2.2

1.9

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

860

1.07

0.25

1.3

—

55.92

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

970

0.93

0.23

1.5

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.25

0.22

1.4

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

181

1.16

0.22

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.25

0.22

1.0

1.8

—

0.56

—

(3044290) Cell count panel - Cerebral spinal fluid

276

1.13

0.22

1.6

1.3

—

(3000034) Microalbumin [Mass/volume] in Urine

107

1.22

0.21

2.5

2.7

32.74

18.13

mg/l

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.19

0.21

1.6

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.19

0.21

1.2

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.1

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

2.1

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.00

0.21

0.0

4.5

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.21

0.0

2.7

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.00

0.21

0.0

2.2

—

(3025130) Human papilloma virus identified in Specimen

102

0.78

0.21

1.5

1.8

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.21

0.0

1.4

—

(3034092) Cytoplasmic Ig cells/cells in Blood

0.00

0.21

0.0

3.4

—

0.15

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

0.00

0.20

0.0

1.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

0.00

0.20

0.0

1.0

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

108

1.21

0.20

1.4

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

1.20

0.19

1.0

—

0.30

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.15

0.19

1.0

2.4

14.22

171.74

ug/l

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.21

0.18

1.0

2.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

121

0.83

0.18

1.2

7.40

12.52

u/l

—

109

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

381

0.92

0.16

2.9

3.7

318.86

1127.25

u/ml

0.60

361

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

130

1.16

0.15

2.1

1.4

—

(3029075) Extractable nuclear Ab panel - Serum

1.15

0.15

1.0

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

1.13

0.15

1.4

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

938

1.05

0.15

2.5

9.90

18.95

au/ml

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

1.10

0.15

1.8

2.7

674.67

600.06

e6/l

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

0.81

0.14

1.9

2.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.81

0.13

1.6

1.2

—

(40768793) Breast Pathology biopsy report

247

1.09

0.13

1.5

1.3

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

1.18

0.12

2.8

3.0

271.60

224.67

e6/l

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

115

1.13

0.10

1.0

275.50

339.79

ng/l

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.15

0.10

1.3

1.5

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

310

1.07

0.10

1.2

4.45

3.70

mmol/l

1.71

287

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

135

1.11

0.09

2.2

1.6

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

1.15

0.09

1.1

1.0

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

116

1.12

0.09

1.0

1030.29

699.23

ng/l

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

116

1.12

0.09

1.0

28.10

45.13

ng/l

—

(1002224) Polysomnography panel

586

1.04

0.09

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.05

0.08

1.0

2.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.05

0.08

1.0

2.2

—

(3020650) Glucose [Presence] in Urine

0.82

0.08

1.4

1.8

0.00

0.05

estimate

—

(40765096) Chromosome analysis panel by Banding

0.82

0.08

1.2

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

1.14

0.08

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.83

0.07

1.0

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.05

0.07

3.5

2.0

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

353

1.05

0.07

1.4

1.2

569.38

612.22

mg/l

0.25

329

(4268621) Lupus anticoagulant assay

153

0.91

0.07

1.8

2.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

167

1.08

0.07

1.6

1.4

7.82

6.25

mmol/l

1.27

154

(44806118) Parainfluenza type 4 nucleic acid detection

182

0.93

0.05

2.2

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

182

0.93

0.05

2.2

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

182

0.93

0.05

2.2

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

182

0.93

0.05

2.2

1.5

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

131

0.92

0.05

1.5

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

1.10

0.04

1.2

1.1

234.70

292.55

mg/l

—

(3002523) Influenza virus A Ag [Presence] in Specimen

200

1.05

0.03

1.2

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

201

1.05

0.03

1.2

1.1

—

(3008898) HLA-B27 [Presence]

380

1.03

0.03

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

148

0.95

0.02

1.1

0.69

0.86

u/ml

—

(4034850) Laboratory test

468

0.98

0.01

20.4

9.9

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

283

1.03

0.01

1.2

1.3

205.23

194.39

miu/ml

0.06

108

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.06

0.01

1.3

1.5

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

144

1.04

0.00

1.0

1.2

—

86.38

—

(3011412) CD3 cells [#/volume] in Blood

126

1.03

0.00

1.6

2.4

1319.77

1179.47

e6/l

0.20

115

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

348

1.01

0.00

1.3

1.2

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

0.96

0.00

1.1

1.3

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

0.00

0.0

2.6

—

166.20

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

249.80

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

0.96

0.00

1.1

1.3

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.0

—

2.00

—

(3013862) HLA-DP [Type]

0.00

-0.00

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

-0.00

0.0

1.3

—

(3013466) aPTT in Blood by Coagulation assay

0.00

-0.00

0.0

1.0

—

35.65

—

(40760410) HLA-B [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.00

-0.00

1.1

1.2

—

(46236302) HLA-C [Type] by High resolution typing

0.00

-0.00

0.0

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

0.97

-0.00

3.3

3.7

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3022475) Manganese [Moles/volume] in Blood

0.00

-0.00

0.0

1.0

—

0.17

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.7

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

-0.00

0.0

1.2

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

-0.00

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint E4_HYPERLIPMIX and mortality.

Females

Parameter	HR [95% CI]	p-value
E4_HYPERLIPMIX	1.44 [1.28, 1.62]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.339

During the follow-up period (1.1.1998 — 31.12.2019), 748 out of 2730 females with E4_HYPERLIPMIX died.

Males

Parameter	HR [95% CI]	p-value
E4_HYPERLIPMIX	1.599 [1.45, 1.76]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.007

During the follow-up period (1.1.1998 — 31.12.2019), 1357 out of 4799 males with E4_HYPERLIPMIX died.

Mortality risk

Mortality risk for people of age

years, who have E4_HYPERLIPMIX.

N-year risk	Females	Males
1	0.169%	0.275%
5	0.803%	1.708%
10	2.097%	4.536%
15	4.065%	8.75%
20	7.427%	14.817%

Relationships between endpoints

↥

Index endpoint: E4_HYPERLIPMIX – Mixed hyperlipidaemia

GWS hits: 7

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Mixed hyperlipidaemia

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints